CleanSpark (CLSK) 10-Q 11 May 20 2020 Q2 Quarterly report Financial data

Cover

Cover - shares	6 Months Ended
	Mar. 31, 2020	May 11, 2020
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Mar. 31, 2020
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2020
Current Fiscal Year End Date	--09-30
Entity Registrant Name	CleanSpark, Inc.
Entity Central Index Key	0000827876
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		9,864,656

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Mar. 31, 2020	Sep. 30, 2019
Current assets
Cash	$ 4,506,510	$ 7,838,857
Accounts receivable, net	1,441,512	777,716
Contract assets	4,282	57,077
Prepaid expense and other current assets	595,831	1,210,395
Derivative asset	824,891
Investment in equity securities	252,000
Investment available for sale debt security, at fair value	456,744
Total current assets	8,331,770	9,884,045
Fixed assets, net	143,895	145,070
Operating lease right of use asset	63,554
Capitalized Software, net	1,060,417	1,055,197
Intangible assets, net	7,328,789	7,430,082
Goodwill	5,562,246	4,919,858
Total assets	22,490,671	23,434,252
Current liabilities
Accounts payable and accrued liabilities	3,121,117	848,756
Contract liabilities	590,241	499,401
Lease liability	64,033
Due to related parties	20,000	86,966
Convertible note, net of unamortized discounts	822,498
Loans payable, net of unamortized discounts		67,467
Total current liabilities	4,617,889	1,502,590
Long- term liabilities
Convertible notes, net of unamortized discounts	5,124,658	2,896,321
Loans payable	150,000	150,000
Total liabilities	9,892,547	4,548,911
Stockholders' equity
Common stock; $0.001 par value; 20,000,000 shares authorized; 5,745,115 and 4,679,018 shares issued and outstanding as of March 31, 2020 and September 30, 2019, respectively	5,745	4,679
Preferred stock; $0.001 par value; 10,000,000 shares authorized; 1,750,000 and 1,000,000 Series A shares issued and outstanding as of March 31, 2020 and September 30, 2019, respectively	1,750	1,000
Additional paid-in capital	113,378,444	111,936,125
Accumulated deficit	(100,787,815)	(93,056,463)
Total stockholders' equity	12,598,124	18,885,341
Total liabilities and stockholders' equity	$ 22,490,671	$ 23,434,252

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - $ / shares	Mar. 31, 2020	Jan. 31, 2020	Sep. 30, 2019	Aug. 09, 2019	Aug. 08, 2019	Jan. 22, 2019
Common Stock, par value	$ 0.001		$ 0.001
Common Stock, Shares authorized	20,000,000		100,000,000	200,000,000	100,000,000
Common Stock, shares issued	5,745,415	95,699	4,679,018			175,000
Preferred Stock, par value	$ 0.001		$ 0.001
Preferred Stock, Shares authorized	10,000,000		10,000,000
Preferred Stock, shares issued and outstanding	1,750,000		1,000,000
Series A Preferred Stock
Preferred Stock, shares issued and outstanding	1,750,000		1,000,000

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($)	3 Months Ended		6 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Mar. 31, 2020	Mar. 31, 2019
Revenues, net
Sale of goods revenues	$ 3,352,098	$ 373,568	$ 4,277,494	$ 373,568
Service, software and related revenues	306,185	350,331	357,613	613,238
Total revenues, net	3,658,283	723,899	4,635,107	986,806
Cost of revenues
Cost of goods sold	2,921,548	330,882	3,706,122	330,882
Cost of services	32,698	261,136	130,845	484,462
Total cost of revenues	2,954,246	592,018	3,836,967	815,344
Gross profit	704,037	131,881	798,140	171,462
Operating expenses
Professional fees	1,005,991	1,406,269	2,522,578	2,422,276
Payroll expenses	984,380	313,170	1,695,919	473,521
Product development		341,081		689,741
General and administrative expenses	311,131	159,408	541,792	256,397
Depreciation and amortization	674,587	499,636	1,301,364	657,119
Total operating expenses	2,976,089	2,719,564	6,061,653	4,499,054
Loss from operations	(2,272,052)	(2,587,683)	(5,263,513)	(4,327,592)
Other income (expense)
Gain/(Loss) on settlement of debt		6,800		(19,425)
Unrealized gain/(loss) on equity securities	(210,000)		158,868
Gain/(loss) on derivative asset	(1,441,763)		824,891
Interest expense (net)	(1,891,283)	(5,183,657)	(3,451,598)	(5,701,074)
Total other income (expense)	(3,543,046)	(5,176,857)	(2,467,839)	(5,720,499)
Net loss	$ (5,815,098)	$ (7,764,540)	$ (7,731,352)	$ (10,048,091)
Loss per common share - basic and diluted	$ (1.13)	$ (1.88)	$ (1.56)	$ (2.59)
Weighted average common shares outstanding - basic and diluted	5,135,802	4,121,963	4,957,491	3,884,818

Consolidated Shareholders Equit

Consolidated Shareholders Equity (Unaudited) - USD ($)	Preferred Stock	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Total
Beginning balance, shares at Sep. 30, 2018	1,000,000	3,611,645
Beginning balance, amount at Sep. 30, 2018	$ 1,000	$ 3,612	$ 82,990,994	$ (66,939,531)	$ 16,056,075
Shares issued for services, shares		12,000
Shares issued for services, amount		$ 12	271,719		271,731
Option and warrants issued for services, shares
Option and warrants issued for services, amount			377,475		377,475
Shares issued under acquisition, shares
Shares issued under acquisition, amount
Shares issued upon Conversion of debt and accrued interest, shares
Shares issued upon Conversion of debt and accrued interest, amount
Shares issued upon exercise of warrants, shares		300
Shares issued upon exercise of warrants, amount			1,088		1,088
Shares and warrants issued under asset purchase agreement, shares
Shares and warrants issued under asset purchase agreement, amount
Beneficial conversion feature and shares and warrants issued with convertible debt, shares		10,000
Beneficial conversion feature and shares and warrants issued with convertible debt, amount		$ 10	4,994,990		4,995,000
Shares issued for direct investment, shares		45,225
Shares issued for direct investment, amount		$ 45	361,755		361,800
Shares issued for settlement of debt, shares		2,500
Shares issued for settlement of debt, amount		$ 3	51,222		51,225
Commitment shares returned and cancelled, shares		(13,750)
Commitment shares returned and cancelled, amount		$ (14)	14
Rounding shares issued for stock split, shares
Rounding shares issued for stock split, amount
Net loss				(2,283,551)	(2,283,551)
Ending balance, shares at Dec. 31, 2018	1,000,000	3,667,920
Ending balance, amount at Dec. 31, 2018	$ 1,000	$ 3,668	89,049,257	(69,223,082)	19,830,843
Beginning balance, shares at Sep. 30, 2018	1,000,000	3,611,645
Beginning balance, amount at Sep. 30, 2018	$ 1,000	$ 3,612	82,990,994	(66,939,531)	16,056,075
Beneficial conversion feature and shares and warrants issued with convertible debt, amount
Net loss					(10,048,091)
Ending balance, shares at Mar. 31, 2019	1,000,000	4,305,928
Ending balance, amount at Mar. 31, 2019	$ 1,000	$ 4,306	100,525,219	(76,987,622)	23,542,903
Beginning balance, shares at Dec. 31, 2018	1,000,000	3,667,920
Beginning balance, amount at Dec. 31, 2018	$ 1,000	$ 3,668	89,049,257	(69,223,082)	19,830,843
Shares issued for services, shares		9,000
Shares issued for services, amount		$ 9	328,679		328,688
Option and warrants issued for services, shares
Option and warrants issued for services, amount			350,888		350,888
Shares issued under acquisition, shares
Shares issued under acquisition, amount
Shares issued upon Conversion of debt and accrued interest, shares		249,862
Shares issued upon Conversion of debt and accrued interest, amount		$ 250	4,724,750		4,725,000
Shares issued upon exercise of warrants, shares		217,896
Shares issued upon exercise of warrants, amount		$ 218	(218)
Shares and warrants issued under asset purchase agreement, shares		175,000
Shares and warrants issued under asset purchase agreement, amount		$ 175	6,071,849		6,072,024
Beneficial conversion feature and shares and warrants issued with convertible debt, shares
Beneficial conversion feature and shares and warrants issued with convertible debt, amount
Shares issued for direct investment, shares
Shares issued for direct investment, amount
Shares issued for settlement of debt, shares
Shares issued for settlement of debt, amount
Commitment shares returned and cancelled, shares		(13,750)
Commitment shares returned and cancelled, amount		$ (14)	14
Rounding shares issued for stock split, shares
Rounding shares issued for stock split, amount
Net loss				(7,764,540)	(7,764,540)
Ending balance, shares at Mar. 31, 2019	1,000,000	4,305,928
Ending balance, amount at Mar. 31, 2019	$ 1,000	$ 4,306	100,525,219	(76,987,622)	23,542,903
Beginning balance, shares at Sep. 30, 2019	1,000,000	4,679,018
Beginning balance, amount at Sep. 30, 2019	$ 1,000	$ 4,679	111,936,125	(93,056,463)	18,885,341
Shares issued for services, shares	750,000	2,000
Shares issued for services, amount	$ 750	$ 2	33,348		34,100
Option and warrants issued for services, shares
Option and warrants issued for services, amount			602,169		602,169
Shares issued under acquisition, shares
Shares issued under acquisition, amount
Shares issued upon Conversion of debt and accrued interest, shares		187,100
Shares issued upon Conversion of debt and accrued interest, amount		$ 187	(187)
Shares issued upon exercise of warrants, shares
Shares issued upon exercise of warrants, amount
Shares and warrants issued under asset purchase agreement, shares
Shares and warrants issued under asset purchase agreement, amount
Beneficial conversion feature and shares and warrants issued with convertible debt, shares
Beneficial conversion feature and shares and warrants issued with convertible debt, amount
Shares issued for direct investment, shares
Shares issued for direct investment, amount
Shares issued for settlement of debt, shares
Shares issued for settlement of debt, amount
Commitment shares returned and cancelled, shares
Commitment shares returned and cancelled, amount
Rounding shares issued for stock split, shares		793
Rounding shares issued for stock split, amount		$ 1	(1)
Net loss				(1,916,254)	(1,916,254)
Ending balance, shares at Dec. 31, 2019	1,750,000	4,868,911
Ending balance, amount at Dec. 31, 2019	$ 1,750	$ 4,869	112,571,454	(94,972,717)	17,605,356
Beginning balance, shares at Sep. 30, 2019	1,000,000	4,679,018
Beginning balance, amount at Sep. 30, 2019	$ 1,000	$ 4,679	111,936,125	(93,056,463)	18,885,341
Beneficial conversion feature and shares and warrants issued with convertible debt, amount					998
Shares issued for direct investment, amount					361,800
Net loss					(7,731,352)
Ending balance, shares at Mar. 31, 2020	1,750,000	5,745,115
Ending balance, amount at Mar. 31, 2020	$ 1,750	$ 5,745	113,378,444	(100,787,815)	12,598,124
Beginning balance, shares at Dec. 31, 2019	1,750,000	4,868,911
Beginning balance, amount at Dec. 31, 2019	$ 1,750	$ 4,869	112,571,454	(94,972,717)	17,605,356
Shares issued for services, shares
Shares issued for services, amount
Option and warrants issued for services, shares
Option and warrants issued for services, amount			273,931		273,931
Shares issued under acquisition, shares		95,699
Shares issued under acquisition, amount		$ 96	444,904		445,000
Shares issued upon Conversion of debt and accrued interest, shares		810,505
Shares issued upon Conversion of debt and accrued interest, amount		$ 810	(810)
Shares issued upon exercise of warrants, shares
Shares issued upon exercise of warrants, amount
Shares and warrants issued under asset purchase agreement, shares
Shares and warrants issued under asset purchase agreement, amount
Beneficial conversion feature and shares and warrants issued with convertible debt, shares
Beneficial conversion feature and shares and warrants issued with convertible debt, amount
Shares issued for direct investment, shares
Shares issued for direct investment, amount
Shares issued for settlement of debt, shares
Shares issued for settlement of debt, amount
Options issued for business acquisition, shares
Options issued for business acquisition, amount			88,935		88,935
Commitment shares returned and cancelled, shares		(30,000)
Commitment shares returned and cancelled, amount		$ (30)	30
Rounding shares issued for stock split, shares
Rounding shares issued for stock split, amount
Net loss				(5,815,098)	(5,815,098)
Ending balance, shares at Mar. 31, 2020	1,750,000	5,745,115
Ending balance, amount at Mar. 31, 2020	$ 1,750	$ 5,745	$ 113,378,444	$ (100,787,815)	$ 12,598,124

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($)	6 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Cash Flows from Operating Activities
Net loss	$ (7,731,352)	$ (10,048,091)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock based compensation	91,045	1,283,782
Unrealized gain on equity securities	(158,868)
Amortization of operating lease right of use asset	21,726
Depreciation and amortization	1,301,364	657,119
Amortization of capitalized software	79,705	689,741
Loss on settlement of debt		19,425
Gain on derivative asset	(824,891)
Amortization of debt discount	3,000,959	5,605,182
Changes in operating assets and liabilities
(Increase) decrease in prepaid expenses and other current assets	618,614	(259,541)
Decrease in contract assets	52,795	54,681
Increase in contract liabilities, net	90,840
(Increase) decrease in accounts receivable	(588,229)	(396,003)
Increase in accounts payable	2,052,295	128,267
Decrease in lease liability	(21,247)
Increase (decrease) in due to related parties	(66,966)	(242,424)
Net cash used in operating activities	(1,263,055)	(2,507,862)
Cash Flows from investing
Purchase of fixed assets	(24,910)	(25,627)
Acquisition of p2kLabs	1,141,990
Investment in capitalized software	(84,925)	(331,053)
Investment in debt and equity securities	(750,000)
Net cash used in investing activities	(2,001,825)	(356,680)
Cash Flows from Financing Activities
Payments on promissory notes	(67,467)	(481,675)
Proceeds from promissory notes		78,603
Proceeds from related party debts		75,030
Payments on related party debts		(457,820)
Proceeds from convertible debt, net of issuance costs		4,995,000
Payments on convertible debts		555,000
Proceeds from exercise of warrants		1,088
Proceeds from issuance of common stock		361,800
Net cash (used in) provided by financing activities	(67,467)	4,017,026
Net increase (decrease) in Cash	(3,332,347)	1,152,484
Cash, beginning of period	7,838,857	412,777
Cash, end of period	4,506,510	1,565,261
Supplemental disclosure of cash flow information
Cash paid for interest	7,606	49,750
Cash paid for tax
Non-cash investing and financing transactions
Day one recognition of right of use asset and liability	85,280
Shares issued for conversion of debt	$ 998
Shares and options issued for business acquisition
Shares issued as collateral returned to treasury	30	275
Stock issued to promissory notes		$ 51,225
Debt discount on convertible debt		4,995,000
Shares and warrants issued for asset acquisition		6,070,274
Shares issued for conversion of debt and accrued interest		4,725,000
Cashless exercise of options		$ 2,179
Option expense capitalized as software development costs		45,000

ORGANIZATION AND LINE OF BUSINE

ORGANIZATION AND LINE OF BUSINESS	6 Months Ended
	Mar. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization and Line of Business	Organization CleanSpark, Inc. (“CleanSpark”, “we”, “our”, the "Company") was incorporated in the state of Nevada on October 15, 1987 as SmartData Corporation. SmartData conducted a 504-public offering in the State of Nevada in December 1987 and began trading publicly in January 1988. Due to a series of unfortunate events, including the untimely death of the founding CEO, SmartData discontinued active business operations in 1992. On March 25, 2014, we began operations in the alternative energy sector. In December 2014, the Company changed its name to Stratean Inc. through a short-form merger in order to better reflect its new business plan. On July 1, 2016, the Company entered into an Asset Purchase Agreement, as amended (the “Purchase Agreement”), with CleanSpark Holdings LLC, CleanSpark LLC, CleanSpark Technologies LLC and Specialized Energy Solutions, Inc. (together, the “Seller”). Pursuant to the Purchase Agreement, the Company acquired CleanSpark, LLC and all the assets related to the Seller and its line of business and assumed $200,000 in liabilities. In October 2016, the Company changed its name to CleanSpark, Inc. through a short-form merger in order to better reflect the brand identity. On January 22, 2019, CleanSpark entered into an Agreement with Pioneer Critical Power, Inc., whereby it acquired certain intellectual property assets and a customer list. As consideration the Company issued to its sole shareholder (i) 175,000 of the common stock of CleanSpark, (ii) a five-year warrant to purchase 50,000 shares of CleanSpark common stock at an exercise price of $16.00 per share, and (iii) a five-year warrant to purchase 50,000 shares of CleanSpark common stock at an exercise price of $20.00 per share. As a result of the transaction Pioneer Critical Power Inc. became a wholly owned subsidiary of CleanSpark Inc. On February 1, 2019, Pioneer Critical Power, Inc. was renamed to CleanSpark Critical Power Systems, Inc. On December 10, 2019, the Financial Industry Regulatory Authority (“FINRA”) approved the 1:10 reverse stock split of the Company’s common stock. The reverse stock split took effect on December 11, 2019. Unless otherwise noted, impacted amounts and share information in this report and included in the financial statements and notes thereto as of and for the period ended March 31, 2020 and September 30, 2019, have been adjusted for the stock split as if such stock split occurred on the first day of the first period presented. On January 31, 2020, the Company entered into a Stock Purchase Agreement (the “Agreement”) with p2klabs, Inc., a Nevada corporation (“p2k”), and its sole stockholder, Amer Tadayon (“Seller”), whereby the Company purchased all of the issued and outstanding shares of p2k from the Seller (the “Transaction”) in exchange for an aggregate purchase price of cash and equity of $1,688,935. The Transaction closed simultaneously upon the execution of the Agreement by the parties on January 31, 2020. As a result of the Transaction, p2k, is now a wholly-owned subsidiary of the Company. (See note 3 for details.) Line of Business Through CleanSpark, LLC, the Company provides microgrid solutions to military, commercial and residential properties. The services offered consist of, microgrid design, engineering and consulting services. The work is generally performed under fixed price bid contracts and negotiated price contracts. Through CleanSpark Critical Power Systems, Inc., the Company provides custom hardware solutions for distributed energy systems that serve military and commercial residential properties. The equipment is generally sold under negotiated fixed price contracts. Through p2kLabs, Inc., the Company provides design, software development and other technology-based consulting services. The services provided are generally an hourly arrangement or fixed-fee project-based arrangements.

SUMMARY OF SIGNIFICANT POLICIES

SUMMARY OF SIGNIFICANT POLICIES	6 Months Ended
	Mar. 31, 2020
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT POLICIES	Basis of Presentation and Liquidity The accompanying unaudited interim financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America and the rules of the Securities and Exchange Commission, and should be read in conjunction with the audited financial statements and notes thereto contained in the Company’s most recent Annual Financial Statements filed with the SEC on Form 10-K. In the opinion of management, all adjustments, consisting of normal recurring adjustments, necessary for a fair presentation of financial position and the results of operations for the interim period presented have been reflected herein. The results of operations for the interim period are not necessarily indicative of the results to be expected for the full year. Notes to the financial statements which would substantially duplicate the disclosures contained in the audited financial statements for the most recent fiscal period, as reported in the Form 10-K, have been omitted. The Company has incurred losses for the past several years while developing infrastructure and its software platforms. As shown in the accompanying unaudited consolidated financial statements, the Company incurred net losses of $7,731,352 during the six months ended March 31, 2020. In response to these conditions and to ensure the Company has sufficient capital for ongoing operations for a minimum we Principles of Consolidation The accompanying consolidated financial statements include the accounts of CleanSpark, Inc., and its wholly owned operating subsidiaries, CleanSpark, LLC, CleanSpark, II, LLC, CleanSpark Critical Power Systems Inc. and p2kLabs, Inc. All material intercompany transactions have been eliminated upon consolidation of these entities. Use of estimates Revenue Recognition • Identification of the contract, or contracts, with a customer • Identification of the performance obligations in the contract • Determination of the transaction price • Allocation of the transaction price to the performance obligations in the contract • Recognition of revenue when, or as, the Company satisfies a performance obligation Engineering, Service & Installation or Construction Contracts The Company recognizes engineering and construction contract revenue over time, as performance obligations are satisfied, due to the continuous transfer of control to the customer. Engineering and construction contracts are generally accounted for as a single unit of account (a single performance obligation) and are not segmented between types of services. The Company recognizes revenue based primarily on contract cost incurred to date compared to total estimated contract cost (an input method). The input method is the most faithful depiction of the Company’s performance because it directly measures the value of the services transferred to the customer. Customer-furnished materials, labor and equipment and, in certain cases, subcontractor materials, labor and equipment, are included in revenue and cost of revenue when management believes that the company is acting as a principal rather than as an agent (i.e., the company integrates the materials, labor and equipment into the deliverables promised to the customer). Customer-furnished materials are only included in revenue and cost when the contract includes construction activity and the Company has visibility into the amount the customer is paying for the materials or there is a reasonable basis for estimating the amount. The Company recognizes revenue, but not profit, on certain uninstalled materials that are not specifically produced, fabricated, or constructed for a project. Revenue on these uninstalled materials is recognized when the cost is incurred (when control is transferred). Changes to total estimated contract cost or losses, if any, are recognized in the period in which they are determined as assessed at the contract level. Pre-contract costs are expensed as incurred unless they are expected to be recovered from the client. Project mobilization costs are generally charged to project costs as incurred when they are an integrated part of the performance obligation being transferred to the client. Customer payments on engineering and construction contracts are typically due within 30 to 45 days of billing, depending on the contract. For service contracts (including maintenance contracts) in which the Company has the right to consideration from the customer in an amount that corresponds directly with the value to the customer of the Company’s performance completed to date, revenue is recognized when services are performed and contractually billable. Service contracts that include multiple performance obligations are segmented between types of services. For contracts with multiple performance obligations, the Company allocates the transaction price to each performance obligation using an estimate of the stand-alone selling price of each distinct service in the contract. Revenue recognized on service contracts that have not been billed to clients is classified as a current asset under contract assets on the Consolidated Balance Sheets. Amounts billed to clients in excess of revenue recognized on service contracts to date are classified as a current liability under contract liabilities. Customer payments on service contracts are typically due within 30 days of billing, depending on the contract. Revenues from Sale of Equipment Performance Obligations Satisfied at a point in time. We recognize revenue on agreements for non-customized equipment we sell on a standardized basis to the market at a point in time. We recognize revenue at the point in time that the customer obtains control of the good, which is generally upon shipment or when the customer has physical possession of the product depending on contract terms. We use proof of delivery for certain large equipment with more complex logistics, whereas the delivery of other equipment is estimated based on historical averages of in-transit periods (i.e., time between shipment and delivery). In situations where arrangements include customer acceptance provisions based on seller or customer-specified objective criteria, we recognize revenue when we have concluded that the customer has control of the goods and that acceptance is likely to occur. We generally do not provide for anticipated losses on point in time transactions prior to transferring control of the equipment to the customer. Our billing terms for these point in time equipment contracts vary and generally coincide with shipment to the customer; however, within certain businesses, we receive progress payments from customers for large equipment purchases, which is generally to reserve production slots with our manufacturing partners, which are recorded as contract liabilities. Service Performance obligations satisfied over time. We enter into long-term product service agreements with our customers primarily within our microgrid segment. These agreements require us to provide preventative maintenance, and standby support services that include certain levels of assurance regarding system performance throughout the contract periods, these contracts will generally range from 1 to 10 years. We account for items that are integral to the maintenance of the equipment as part of our service-related performance obligation, unless the customer has a substantive right to make a separate purchasing decision (e.g., equipment upgrade). Contract modifications that extend or revise contract terms are not uncommon and generally result in our recognizing the impact of the revised terms prospectively over the remaining life of the modified contract (i.e., effectively like a new contract). Revenues are recognized for these arrangements on a straight-line basis consistent with the nature, timing and extent of our services, which primarily relate to routine maintenance and as needed product repairs. Our billing terms for these contracts vary, but we generally invoice periodically as services are provided. Contract assets represent revenue recognized in excess of amounts billed and include unbilled receivables (typically for cost reimbursable contracts) of $0 and contract work in progress (typically for fixed-price contracts) of $4,282 and $57,077 as of March 31, 2020 and September 30, 2019, respectively. Unbilled receivables, which represent an unconditional right to payment subject only to the passage of time, are reclassified to accounts receivable when they are billed under the terms of the contract. Advances that are payments on account of contract assets of $611,000 and $360,000 as of March 31, 2020 and September 30, 2019, respectively, have been deducted from contract assets. Contract liabilities represent amounts billed to clients in excess of revenue recognized to date. The Company recorded $590,241 and $499,401 in contract liabilities as of March 31, 2020 and September 30, 2019, respectively. Revenues from software The Company derives its revenue from subscription fees from customers for access to its mVSO platform. The Company’s policy is to exclude sales and other indirect taxes when measuring the transaction price of its subscription agreements. The Company’s subscription agreements generally have monthly or annual contractual terms. Revenue is recognized ratably over the related contractual term beginning on the date that the platform is made available to a customer. Access to the platform represents a series of distinct services as the Company continually provides access to, and fulfills its obligation to the end customer over the subscription term. The series of distinct services represents a single performance obligation that is satisfied over time. Revenues from design, software development and other technology-based consulting services For service contracts performed under Master Services Agreements (“MSA”) and accompanying Statement(s) of Work (“SOW”), revenue is recognized based on the performance obligation(s) outlined in the SOW which is typically hours worked or specific deliverable milestones. In the case of a milestone-based SOW, the Company recognizes revenues as each deliverable is signed off by the customer. Variable Consideration The nature of the Company’s contracts gives rise to several types of variable consideration, including claims and unpriced change orders; awards and incentive fees; and liquidated damages and penalties. The Company recognizes revenue for variable consideration when it is probable that a significant reversal in the amount of cumulative revenue recognized will not occur. The Company estimates the amount of revenue to be recognized on variable consideration using the expected value (i.e., the sum of a probability-weighted amount) or the most likely amount method, whichever is expected to better predict the amount. Factors considered in determining whether revenue associated with claims (including change orders in dispute and unapproved change orders in regard to both scope and price) should be recognized include the following: (a) the contract or other evidence provides a legal basis for the claim, (b) additional costs were caused by circumstances that were unforeseen at the contract date and not the result of deficiencies in the company’s performance, (c) claim-related costs are identifiable and considered reasonable in view of the work performed, and (d) evidence supporting the claim is objective and verifiable. If the requirements for recognizing revenue for claims or unapproved change orders are met, revenue is recorded only when the costs associated with the claims or unapproved change orders have been incurred. Back charges to suppliers or subcontractors are recognized as a reduction of cost when it is determined that recovery of such cost is probable, and the amounts can be reliably estimated. Disputed back charges are recognized when the same requirements described above for claims accounting have been satisfied. The C Practical Expedients If the company has a right to consideration from a customer in an amount that corresponds directly with the value of the company’s performance completed to date (a service contract in which the company bills a fixed amount for each hour of service provided), the company recognizes revenue in the amount to which it has a right to invoice for services performed. The company does not adjust the contract price for the effects of a significant financing component if the company expects, at contract inception, that the period between when the company transfers a service to a customer and when the customer pays for that service will be one year or less. The company has made an accounting policy election to exclude from the measurement of the transaction price all taxes assessed by governmental authorities that are collected by the company from its customers (use taxes, value added taxes, some excise taxes). For the six months ended March 31, 2020 and 2019, the Company reported revenues of $4,635,107 and $986,806, respectively. Cash and cash equivalents Accounts receivable and $254,570 at March 31, 2020, and September 30, 2019, respectively. Retention receivable is the amount withheld by a customer until a contract is completed. Retention receivables of $158,300 and $159,989 were included in the balance of trade accounts receivable as of March 31, 2020 and September 30, 2019, respectively. Investment securities Interest income is recognized based on the coupon rate and increased by accretion of discounts earned or decreased by the amortization of premiums paid over the contractual life of the security. For individual debt securities where the Company either intends to sell the security or more likely than not will not recover all of its amortized cost, the OTTI is recognized in earnings equal to the entire difference between the security's cost basis and its fair value at the balance sheet date. For individual debt securities for which a credit loss has been recognized in earnings, interest accruals and amortization and accretion of premiums and discounts are suspended when the credit loss is recognized. Interest received after accruals have been suspended is recognized in income on a cash basis. The Company holds investments in both publicly held and privately held equity securities. Privately held equity securities are recorded at cost and adjusted for observable transactions for same or similar investments of the issuer (referred to as the measurement alternative) or impairment. All gains and losses on privately held equity securities, realized or unrealized, are recorded through gains or losses on equity securities on the consolidated statement of operations. Publicly held equity securities are based on fair value accounting with unrealized gains or losses resulting from changes in fair value reflected as unrealized gains or losses on equity securities in our consolidated statement of operations. Concentration Risk At times throughout the year, the Company may maintain cash balances in certain bank accounts in excess of FDIC limits. As of March 31, 2020, the cash balance in excess of the FDIC limits was $4,256,510. The Company has not experienced any losses in such accounts and believes it is not exposed to any significant credit risk in these accounts. The Company had certain customers whose revenue individually represented 10% or more of the Company’s total revenue. (See Note 14 for details.) Warranty Liability Stock-based compensation Compensation-Stock Compensation, received in exchange for an award of an equity instrument based on the grant-date fair value of the award. Stock-based compensation expense is recognized on a straight-line basis over the requisite service period. The Company may issue compensatory shares for services including, but not limited to, executive, management, accounting, operations, corporate communication, financial and administrative consulting services. Earnings (loss) per share Earnings Per Share, shares issuable upon exercise of outstanding options, warrants and convertible debt which have been excluded as anti-dilutive. Fair value of financial instruments and derivative asset Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value maximize the use of observable inputs and minimize the use of unobservable inputs. The Company utilizes a fair value hierarchy based on three levels of inputs, of which the first two are considered observable and the last unobservable. • Level 1 Quoted prices in active markets for identical assets or liabilities. These are typically obtained from real-time quotes for transactions in active exchange markets involving identical assets. • Level 2 Quoted prices for similar assets and liabilities in active markets; quoted prices included for identical or similar assets and liabilities that are not active; and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets. These are typically obtained from readily-available pricing sources for comparable instruments. • Level 3 Unobservable inputs, where there is little or no market activity for the asset or liability. These inputs reflect the reporting entity’s own beliefs about the assumptions that market participants would use in pricing the asset or liability, based on the best information available in the circumstances. The following table presents the Company’s financial instruments that are measured and recorded at fair value on the Company’s balance sh eets on a recurring basis, and their level within the fair value hierarchy as of March 31, 2020: Amount Level 1 Level 2 Level 3 Derivative asset $ 824,891 $ — $ — $ 824,891 Investment in equity security 252,000 252,000 — $ — Investment debt security 456,744 — — 456,744 Total $ 1,533,635 $ 252,000 $ — $ 1,281,635 The below table presents the change in the fair value of the derivative asset and investment in debt security during the six months ended March 31, 2020: Amount Balance at September 30, 2019 $ — Fair value at issuance, net of premium 456,744 Gain on derivative asset 824,891 Balance at March 31, 2020 $ 1,281,635 Reclassifications Recently issued accounting pronouncements In June 2018, the FASB issued ASU 2018-07, "Compensation-Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting," which modifies the accounting for share-based payment awards issued to nonemployees to largely align it with the accounting for share-based payment awards issued to employees. ASU 2018-07 is effective for us for annual periods beginning October 1, 2019. The new standard did not have a material impact on the Company’s results of operations or cash flows. In August 2018, the FASB issued ASU 2018-15, "Intangibles-Goodwill and Other-Internal-Use Software (Subtopic 350-40): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract," which allows for the capitalization of certain implementation costs incurred in a hosting arrangement that is a service contract. ASU 2018-15 allows for either retrospective adoption or prospective adoption to all implementation costs incurred after the date of adoption. ASU 2018-15 is effective for fiscal years beginning after December 15, 2019. We are currently evaluating the impact the adoption of this new standard will have on our financial position and results of operations. In February 2016, the FASB issued guidance within ASU 2016-02, Leases Leases Leases (Topic 842) Targeted Improvements continue to apply the legacy guidance in ASC 840, Leases In January, 2017 the FASB issued guidance within ASU 2017-01, Business Combinations. The amendments in ASU 2017-01 Clarify the definition of a business by providing a framework to use in determining when a set of assets is a business. ASU 2017-01 is effective for us for annual periods beginning October 1, 2019. The new standard did not have a material impact on the Company’s results of operations or cash flows. In January, 2017 the FASB issued guidance within ASU 2017-04, Intangibles-Goodwill and Other. The amendments in ASU 2017-04 simplify the subsequent measurement of goodwill by comparing the fair value of a reporting unit with its carrying amount. ASU 2017-04 is effective for fiscal years beginning after December 15, 2019. We are currently evaluating the impact the adoption of this new standard will have on our financial position and results of operations. The Company has evaluated all other recent accounting pronouncements, and believes that none of them will have a material effect on the Company's financial position, results of operations or cash flows.

ACQUISITION OF P2K LABS, INC.

ACQUISITION OF P2K LABS, INC.	6 Months Ended
	Mar. 31, 2020
Accounting Policies [Abstract]
ACQUISITION OF P2K LABS, INC.	On January 31, 2020, the Company, entered into an Agreement with p2k, and its sole stockholder, Amer Tadayon, whereby the Company purchased all of the issued and outstanding shares of p2k in exchange for an aggregate purchase price of cash and equity of $1,688,935. The Transaction closed simultaneously upon the execution of the Agreement by the parties on January 31, 2020. As a result of the Transaction, p2k is now a wholly-owned subsidiary of the Company. Pursuant to the terms of the Agreement, the purchase price was as follows: a) $1,039,500 in cash was paid to the Seller; b) 31,183 restricted shares of the Company’s common stock, valued at $145,000, were issued to the Seller (the “Shares”). The Shares are subject to certain lock-up and leak-out provisions whereby the Seller may sell an amount of Shares equal to ten percent (10%) of the daily dollar trading volume of the Company’s common stock on its principal market for the prior 30 days (the “Leak-Out Terms”); c) $115,500 in cash was paid to an independent third-party escrow where such cash is subject to offset for adjustments to the purchase price and indemnification purposes; and d) 64,516 restricted shares of the Company’s common stock, valued at $300,000, were issued to an independent third-party escrow (the “Holdback Shares”). The Holdback Shares will be released to Seller once p2k achieves certain revenue milestones for the future performance of p2k. The Holdback Shares will also be subject to the Leak-Out Terms once they are released from escrow 12 months from closing. The Shares and Holdback Shares were deemed to have a fair market value of $4.65 per share which was the closing price of the Company’s common stock on January 31, 2020. e) 26,950 Common Stock options which were deemed to have a fair market value of $88,935 on the date of the closing of the Transaction. The Company accounted for the acquisition of p2k as an acquisition of a business under ASC 805. The Company determined the fair value of the consideration given to the Seller in connection with the Transaction in accordance with ASC 820 was as follows: Consideration: Fair Value Cash $ 1,155,000 95,699 shares of common stock $ 445,000 26,950 common stock options $ 88,935 Total Consideration $ 1,688,935 The total purchase price was allocated to identifiable assets deemed acquired, and liabilities assumed, of the Company’s acquisition of p2k, based on their estimated fair values as indicated below. The business combination accounting is not yet complete and the amounts assigned to the assets acquired and the liabilities assumed are provisional. Therefore, this may result in future adjustments to the provisional amounts as new information is obtained about the facts and circumstances that existed at the acquisition date. Purchase Price Allocation: Customer list $ 1,045,000 Design and other assets $ 123,000 Goodwill $ 642,388 Other assets and liabilities assumed, net $ (121,453) Total $ 1,688,935 The following is the unaudited pro forma information assuming the acquisition of p2k occurred on October 1, 2018: For the Three Months Ended For the Six Months Ended March 31, 2020 March 31, 2019 March 31, 2020 March 31, 2019 Net sales $ 3,716,725 $ 924,906 $ 5,006,806 $ 1,409,906 Net loss $ (5,970,217 ) $ (7,770,325 ) $ (7,851,673 ) $ (10,044,709) Loss per common share - basic and diluted $ (1.15 ) $ (1.84 ) $ (1.56 ) $ (2.52) Weighted average common shares outstanding - basic and diluted 5,188,384 4,217,662 5,031,749 3,980,517 The unaudited pro forma consolidated financial results have been prepared for illustrative purposes only and do not purport to be indicative of the results of operations that actually would have resulted had the acquisition occurred on the first day of the earliest period presented, or of future results of the consolidated entities. The unaudited pro forma consolidated financial information does not reflect any operating efficiencies and cost savings that may be realized from the integration of the acquisition. All transitions that would be considered inter-company transactions for proforma purposes have been eliminated.

INVESTMENTS IN INTERNATIONAL LA

INVESTMENTS IN INTERNATIONAL LAND ALLIANCE	6 Months Ended
	Mar. 31, 2020
Schedule of Investments [Abstract]
INVESTMENTS IN INTERNATIONAL LAND ALLIANCE	International Land Alliance, Inc. On November 5, 2019, CleanSpark entered into a binding Memorandum of Understanding (the “MOU”) with International Land Alliance, Inc., a Wyoming corporation (“ILAL”), in order to lay a foundational framework where the Company will deploy its energy solutions products and services to ILAL, its energy projects, and its customers. Pursuant to the terms of the MOU, the parties will work in good faith and pursue the following priorities over the next twelve (12) months: 1) The Company will perform feasibility studies to outline the details and scope of developing microgrid energy solutions to support ILAL projects. 2) ILAL will (a) exclusively sell the Company’s products and services as part of ILAL’s power solution for its offering of off-grid properties, and (b) include the Company’s mPulse DER Energy Manager within the off-grid energy project bids; 3) The Company will provide on-site testing, training, and support services to ILAL’s projects and operations In connection with the MOU, and in order to support the power and energy needs of ILAL’s development and construction of certain projects, the Company entered into a Securities Purchase Agreement, dated as of November 6, 2019, with ILAL (the “SPA”). Pursuant to the terms of the SPA, ILAL sold, and the Company purchased 1,000 shares of Series B Preferred Stock (the “Preferred Stock”) of ILAL for an aggregate purchase price of US $500,000 (the “Stock Transaction”), less certain expenses and fees. The Series B Preferred Stock will accrue cumulative in kind accruals at a rate of 12% per annum and shall increase by 10% per annum upon the occurrence of any trigger event. ILAL may redeem by paying in cash within 9 months from the issuance date. The Preferred Stock becomes convertible into common stock after 9 months or when certain triggering events occur. In the event of a conversion of any shares of the Preferred Stock, the number of conversion shares is equal to the face value of the Preferred Stock divided by the applicable Conversion Price (defined at 65% of the 5 lowest individual daily volume weighted average prices of the Common Stock from issuance to conversion less $0.05 per share, but no less than the Floor Price ($0.01). While the Preferred Stock is outstanding if triggering events occur, the Conversion Rate may be decreased by 10% and the accrual rate increased by 10% for each triggering event. The Company believes that, pursuant to the terms and conditions of the SPA, at least two triggering events have occurred. Under this good faith belief, the Company believes that as a result of the occurrence of these triggering events, the Series B Preferred stock should be convertible at the Company’s option, and the interest and conversion rate should be adjusted by 10% for each such occurrence. The Preferred Stock is recorded as an AFS debt security and is reported at its estimated fair value as of March 31, 2020. As of March 31, 2020, the Company has identified a derivative instrument in accordance with ASC Topic No. 815 due to the variable conversion feature upon certain triggering events that occurred during the period. Topic No. 815 requires the Company to account for the conversion feature on its balance sheet at fair value and account for changes in fair value as a derivative gain or loss. The Black-Scholes model utilized the following inputs to value the derivative asset at the date in which the derivative asset was determined through March 31, 2020. Fair value assumptions: March 31, 2020 Risk free interest rate 0.17% Expected term (months) 4 Expected volatility 152% Expected dividends 0% In connection with the Stock Transaction, ILAL issued 350,000 shares of its common stock to the Company as commitment shares. The commitment shares are recorded at $252,000, or $0.72 per share, which was the quoted price of the shares on March 31, 2020 .

CAPITALIZED SOFTWARE

CAPITALIZED SOFTWARE	6 Months Ended
	Mar. 31, 2020
Fair Value Disclosures [Abstract]
Capitalized Software	Capitalized software consists of the following as of March 31, 2020 and September 30, 2019: March 31, 2020 September 30, 2019 mVSO software $ 437,136 $ 352,211 mPulse software 741,846 741,846 Capitalized Software: 1,178,982 1,094,057 Less: accumulated amortization (118,565 ) (38,860) Capitalized Software, net $ 1,060,417 $ 1,055,197 Capitalized software amortization recorded as cost of revenues and product development expense for the six months ended March 31, 2020 and 2019 was $79,705 and $689,741, respectively.

INTANGIBLE ASSETS

INTANGIBLE ASSETS	6 Months Ended
	Mar. 31, 2020
Accounting Policies [Abstract]
INTANGIBLE ASSETS	Intangible assets consist of the following as of March 31, 2020 and September 30, 2019: March 31, 2020 September 30, 2019 Patents $ 74,112 $ 74,112 Websites 8,115 16,482 Customer list and non-compete agreement 6,767,024 5,722,024 Design assets $ 123,000 — Trademarks 5,928 5,928 Trade secrets 4,370,269 4,370,269 Intangible assets: 11,348,448 10,188,815 Less: accumulated amortization (4,019,659 ) (2,758,733) Intangible assets, net $ 7,328,789 $ 7,430,082 Amortization expense for the six months ended March 31, 2020 and 2019 was $1,269,293 and $635,955, respectively.

FIXED ASSETS

FIXED ASSETS	6 Months Ended
	Mar. 31, 2020
Accounting Policies [Abstract]
FIXED ASSETS	Fixed assets consist of the following as of March 31, 2020 and September 30, 2019: March 31, 2020 September 30, 2019 Machinery and equipment $ 201,856 $ 212,082 Leasehold improvements 17,965 — Furniture and fixtures 110,586 75,121 Total 330,407 287,203 Less: accumulated depreciation (186,512 ) (142,133) Fixed assets, net $ 143,895 $ 145,070 Depreciation expense for the six months ended March 31, 2020 and 2019 was $32,071 and $21,164, respectively.

LOANS

LOANS	6 Months Ended
	Mar. 31, 2020
Accounting Policies [Abstract]
LOANS	Long term Long-term loans payable consist of the following: March 31, 2020 September 30, 2019 Promissory notes $ 150,000 $ 150,000 Total $ 150,000 $ 150,000 Current Current loans payable consist of the following: March 31, 2020 September 30, 2019 Promissory notes $ — $ 50,000 Insurance financing loans — 17,467 Current loans payable: — 67,467 Unamortized debt discount — — Total, net of unamortized discount $ — $ 67,467 Promissory Notes On September 5, 2017, the Company executed a 9% secured promissory note with a face value of $150,000 with an investor. Under the terms of the promissory note, the Company received $150,000 and agreed to make monthly interest payments and repay the note principal 24 months from the date of issuance. On September 5, 2019, the investor extended the maturity date to September 5, 2021 and the modification was not deemed substantial. The note is secured by 15,000 shares which are held in escrow and would be issued to the note holder only in the case of an uncured default. As of March 31, 2020, the Company owed $150,000 in principal and $0 in accrued interest under the terms of the agreement and recorded interest expense of $6,767 and $6,729 during the six months ended March 31, 2020 and 2019, respectively. On November 11, 2017, the Company executed a 10% secured promissory note with a face value of $100,000 with an investor. Under the terms of the promissory note the Company received $100,000 and agreed to make monthly interest payments and repay the note principal 24 months from the date of issuance. The note was secured by 10,000 shares which would be issued to the note holder only in the case of an uncured default. The Company repaid all principal and outstanding interest on August 13, 2019 and the 10,000 shares of common stock held as collateral were returned to treasury and cancelled on August 26, 2019. The Company recorded interest expense of $0 and $4,985 for the six months ended March 31, 2020 and 2019, respectively. On December 5, 2017, the Company executed a 9% secured promissory note with a face value of $50,000 with an investor. Under the terms of the promissory note the Company received $50,000 and agreed to make monthly interest payments and repay the note principal 24 months from the date of issuance. The note was secured by 5,000 shares which would be issued to the note holder only in the case of an uncured default. The Company repaid all principal and outstanding interest on December 5, 2019 and the 5,000 shares of common stock held as collateral were returned to treasury and cancelled on January 13, 2020. The Company recorded interest expense of $802 and $2,247 for the six months ended March 31, 2020 and 2019, respectively. Insurance financing loans On February 11, 2019, the Company executed an unsecured 5.6% installment loan with a total face value of $78,603 with a financial institutional to finance its insurance policies. Under the terms of the installment notes the Company received $76,800 and agreed to make equal payments and repay the note 10 months from the date of issuance. As of September 30, 2019, $17,467 in principal remained outstanding. The Company repaid all principal and outstanding interest on November 4th, 2019.

CONVERTIBLE NOTES PAYABLE

CONVERTIBLE NOTES PAYABLE	6 Months Ended
	Mar. 31, 2020
Debt Disclosure [Abstract]
CONVERTIBLE NOTES PAYABLE	Short-Term convertible notes Securities Purchase Agreement – December 31, 2018 On December 31, 2018, the Company entered into a Securities Purchase Agreement (the “SPA”) with an otherwise unaffiliated third-party institutional investor (the “Investor”), pursuant to which the Company issued to the Investor a Senior Secured Redeemable Convertible Debenture (the “Debenture”) in the aggregate face value of $5,250,000. The note is secured by all assets of the Company. The Debenture has a maturity date of two per annum. Interest is payable on the date the applicable principal is converted or on maturity. The interest must be paid in cash and, in certain circumstances, may be paid in shares of common stock. The transactions described above closed on December 31, 2018. In connection with the issuance of the Debenture and pursuant to the terms of the SPA, the Company issued to the Investor 10,000 shares of common stock and a Common Stock Purchase Warrant to acquire up to 308,333 shares of common stock for a term of three years (the “Warrant”) on a cash-only basis at an exercise price of $20.00 per share with respect to 125,000 Warrant Shares, $25.00 with respect to 100,000 Warrant Shares, $50.00 with respect to 50,000 Warrant Shares and $75.00 with respect to 33,333 Warrant Shares. The warrants and shares issued were fair valued and a debt discount of $4,995,000 was recorded as a result of the issuance of the warrants and shares and the recognition of a beneficial conversion feature on the Debenture. The Company also paid a $5,000 due diligence fee prior to receiving the funding which was also recorded as a debt discount. Pursuant to the terms of the SPA, the Investor agreed to tender to the Company the sum of $5,000,000, of which the Company received the full amount as of the closing. Prior to the maturity date, provided that no trigger event has occurred, the Company will have the right at any time upon 30 trading days’ prior written notice, in its sole and absolute discretion, to redeem all or any portion of the Debenture then outstanding by paying to the Investor an amount equal to 140% of the of the portion of the Debenture being redeemed. The Investor may convert the Debenture into shares of the Company’s common stock at a conversion price equal to 95% of the mathematical average of the 5 lowest individual daily volume weighted average prices of the common stock, less $0.50 per share, during the period beginning on the issuance date and ending on the maturity date subject to certain floor price restrictions. In the event certain equity conditions exist, the Company may require that the Investor convert the Debenture. In no event shall the Debenture be allowed to affect a conversion if such conversion, along with all other shares of Company common stock beneficially owned by the Investor and its affiliates would exceed 4.99% of the outstanding shares of the common stock of the Company. While the note is outstanding if Triggering Events occur the conversion rate may be decreased by 10% and the interest rate increased by 10% for each Triggering Event. On January 7, 2019, the investor converted $2,500,000 in principal and $875,000 in interest as a conversion premium, for 178,473 shares of the Company common stock at an effective conversion price of $18.90, due to a trigger event for the Company not filing its annual report on Form 10-K for the fiscal year ended September 30, 2018 on or before December 31, 2018. On March 6, 2019, the investor converted $1,000,000 in principal and $350,000 in interest as a conversion premium, for 71,389 shares of the Company common stock at an effective conversion price of $18.90, due to a trigger event for the Company not filing its annual report on Form 10-K for the fiscal year ended September 30, 2018 on or before December 31, 2018. On July 9, 2019, in accordance with the terms of the agreement the investor was issued an additional 45,614 shares of common stock due to the decrease in stock price resulting in an effective conversion price of $15.06. On July 16, 2019, in accordance with the terms of the agreement the investor was issued an additional 18,246 shares of common stock due to the decrease in stock price resulting in an effective conversion price of $15.06. On July 19, 2019, an investor converted $500,000 in principal and $175,000 in interest as a conversion premium, for 45,109 shares of the Company common stock at an effective conversion price of $15.00 due to a trigger event for the Company not filing its annual report on Form 10-K for the fiscal year ended September 30, 2018 on or before December 31, 2018. On August 23, 2019, in accordance with the terms of the agreement the investor was issued an additional 43,721 shares of common stock due to the decrease in stock price resulting in an effective conversion price of $7.60. On September 16, 2019, in accordance with the terms of the agreement the investor was issued an additional 61,500 shares of common stock due to the decrease in stock price resulting in an effective conversion price of $7.30. On October 17, 2019, in accordance with the terms of the agreement the investor was issued an additional 90,000 shares of common stock due to the decrease in stock price resulting in an effective conversion price of $3.74. On December 5, 2019, in accordance with the terms of the agreement the investor was issued an additional 97,100 shares of common stock due to the decrease in stock price resulting in an effective conversion price of $3.15. On February 10, 2020, in accordance with the terms of the agreement the investor was issued an additional 100,000 shares of common stock due to the decrease in stock price resulting in an effective conversion price of $3.15. On February 21, 2020, in accordance with the terms of the agreement the investor was issued an additional 108,770 shares of common stock due to the decrease in stock price resulting in an effective conversion price of 2.69. On March 2, 2020, in accordance with the terms of the agreement the investor was issued an additional 167,100 shares of common stock due to the decrease in stock price resulting in an effective conversion price of $1.87. On March 5, 2020, in accordance with the terms of the agreement the investor was issued an additional 154,835 shares of common stock due to the decrease in stock price resulting in an effective conversion price of $1.83. On March 13, 2020, in accordance with the terms of the agreement the investor was issued an additional 116,000 shares of common stock due to the decrease in stock price resulting in an effective conversion price of $1.50. On March 20, 2020, in accordance with the terms of the agreement the investor was issued an additional 163,800 shares of common stock due to the decrease in stock price resulting in an effective conversion price of $1.50. The aggregate debt discount has been accreted and charged to interest expenses as a financing expense in the amount of $355,972 during the six months ended March 31, 2020. The Debenture at March 31, 2020 consists of: Principal $ 1,250,000 Unamortized debt discount (427,502) Total, net of unamortized discount 822,498 On March 4, and March 13, 2020 the Company entered into amendments (the “Amendments”) with the Investor. The Amendments amended the SPA and Debenture, as follows: 1) A Floor Price of $1.50 per share of Common Stock was placed on conversions by the Investor under the Debenture, with the Floor Price on the First Debenture not applying in the occurrence of an event of default; 2) Lowered the closing price of the Common Stock which may trigger an event of default from $5.00 per share to $1.75 per share for 5 consecutive trading days provided that any event of default will not be triggered, if at all, until after June 11, 2020; 3) Deleted the requirement that the Investor convert the Debenture at maturity and 4) Allowed the Company, for a period of 90 days from March 13, 2020, to not reserve or issue to the Investor more shares of Common Stock than were reserved for the Investor prior to March 31, 2020. On April 15, 2020, the Investor fully converted the remaining principal and interest into shares of the Company’s Common Stock. (See note 17 for additional details) Long-Term convertible notes Securities Purchase Agreement – April 17, 2019 On April 17, 2019, the Company entered into a Securities Purchase Agreement (the “Agreement”) with an otherwise unaffiliated third-party institutional investor (the “Investor”), pursuant to which the Company agreed to issue to the Investor a $10,750,000 face value Senior Secured Redeemable Convertible Promissory Note (the “Debenture”) with a 7.5% original issue discount, 215 shares of our Series B Preferred Stock with a 7.5% original issue discount, a Common Stock Purchase Warrant (the “Warrant”) on a cash-only basis to acquire up to 230,000 shares (the “Warrant Shares”) of our common stock and 125,000 shares of our Common Stock. The aggregate purchase price for the Debenture, the Series B Preferred Stock the Warrant and the Common Stock is $20,000,000. (See Notes 12 and 13 for additional details.) The Debenture is secured by all assets of the Company. Pursuant to the first closing of the Agreement, which occurred on April 18, 2019, the Investor agreed to tender to the Company the sum of $10,000,000, for the Debenture, the Common Stock and the Warrant. No additional closings to sell the preferred stock had occurred as of September 30, 2019. The Debenture has a maturity date of two Prior to the maturity date, provided that no trigger event has occurred, the Company will have the right at any time upon 30 trading days’ prior written notice, in its sole and absolute discretion, to redeem all or any portion of the Debenture then outstanding by paying to the Investor an amount equal to 145% of the of the portion of the Debenture being redeemed. The Investor may convert the Debenture into shares of the Company’s common stock at a conversion price equal to 90% of the mathematical average of the 5 lowest individual daily volume weighted average prices of the common stock, less $0.75 per share, during the period beginning on the issuance date and ending on the maturity date subject to certain floor price restrictions. In the event certain equity conditions exist, the Company may require that the Investor convert the Debenture. In no event shall the Debenture be allowed to effect a conversion if such conversion, along with all other shares of Company common stock beneficially owned by the Investor and its affiliates would exceed 4.99% of the outstanding shares of the common stock of the Company. While the note is outstanding if Triggering Events occur the conversion rate may be decreased by 10% and the interest rate increased by 10% for each Triggering Event. The Debenture at March 31, 2020 consists of: Principal $ 10,750,000 Unamortized debt discount (5,625,342) Total, net of unamortized discount $ 5,124,658 The aggregate debt discount has been accreted and charged to interest expenses as a financing expense in the amount of $2,694,863 during the six months ended March 31, 2020. On March 4, and March 13, 2020 the Company entered into amendments (the “Amendments”) with the Investor. The Amendments amended the SPA and Debenture, as follows: 1) A Floor Price of $1.50 per share of Common Stock was placed on conversions by the Investor under the Debenture; 2) Lowered the closing price of the Common Stock which may trigger an event of default from $5.00 per share to $1.75 per share for 5 consecutive trading days provided that any event of default will not be triggered, if at all, until after June 11, 2020; 3) Deleted the requirement that the Investor convert the Debenture at maturity and 4) Allowed the Company, for a period of 90 days from March 13, 2020, to not reserve or issue to the Investor more shares of Common Stock than were reserved for the Investor prior to March 31, 2020. 5) The Company and the Investor also agreed to remove the Second Closing and Company Option to sell an aggregate of an additional $10,000,000 in securities under the Debenture. As a result of these changes, the Company was authorized to terminate any and all documentation related to the 100,000 shares of Series B Preferred Stock that the Company’s Board of Directors had previously voted to designate back on April 16, 2019. On May 5, 2020, the investor converted $750,000 of principal and $112,500 of accrued interest into 575,000 shares of Common Stock. (See note 17 for additional details) On May 6, 2020, the investor converted $600,000 of principal and $90,000 of accrued interest into 460,000 shares of Common Stock. (See note 17 for additional details) On May 7, 2020, the investor converted $595,000 of principal and $87,250 of accrued interest into 456,167 shares of Common Stock. (See note 17 for additional details) On May 8, 2020, the investor converted $350,000 of principal and $52,500 of accrued interest into 268,333 shares of Common Stock. (See note 17 for additional details)

LEASES

LEASES	6 Months Ended
	Mar. 31, 2020
Debt Disclosure [Abstract]
LEASES	On October 1, 2019, the Company adopted the amendments to ASC 842, Leases Leases (Topic 842) Targeted Improvements Leases The Company has operating leases under which it leases its branch offices and corporate headquarters, one of which is with a related party. Upon adoption of the new lease guidance, on October 1, 2019, the Company recorded a right of use asset and corresponding lease liability of $85,280 and $85,280, respectively, on the consolidated balance sheet. As of March 31, 2020, the Company's operating lease right of use asset and operating lease liability totaled $63,554 and $64,033, respectively. A weighted average discount rate of 10% was used in the measurement of the right of use asset and lease liability as of October 1, 2019. As the rate implicit in the lease is not readily determinable, the Company's incremental collateralized borrowing rate is used to determine the present value of lease payments. This rate gives consideration to the applicable Company collateralized borrowing rates and is based on the information available at the commencement date. The Company has elected to apply the short-term lease measurement and recognition exemption to leases with an initial term of 12 months or less; therefore, these leases are not recorded on the Company’s Consolidated Balance Sheet, but rather, lease expense is recognized over the lease term on a straight-line basis. The Company's leases have remaining lease terms between one to two years, with a weighted average lease term of 0.9 years at March 31, 2020. Some leases include multiple year renewal options. The Company’s decision to exercise these renewal options is based on an assessment of its current business needs and market factors at the time of the renewal. Currently, the Company has no leases for which the option to renew is reasonably certain and therefore, options to renew were not factored into the calculation of its right of use asset and lease liability as of October 1, 2019. The following is a schedule of the Company's operating lease liabilities by contractual maturity as of September 30, 2019: Fiscal year ending September 30, 2020 $ 25,448 Fiscal year ending September 30, 2021 43,170 Total Lease Payments 68,618 Less: imputed interest (4,585) Total present value of lease liabilities $ 64,033 Total operating lease costs of $48,459 and $38,523 the six months ended March 31, 2020 and 2019, respectively, were included as part of administrative expense.

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	6 Months Ended
	Mar. 31, 2020
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	Zachary Bradford – Chief Executive Officer, Director and Former Chief Financial Officer During the six months ended March 31, 2019, the Company had a consulting agreement with ZRB Holdings, Inc., an entity wholly owned by Zachary Bradford, our Chief Executive Officer and director, for management services. In accordance with this agreement, as amended, Mr. Bradford earned $190,140, during the six months ended March 31, 2019. The agreement was terminated in October 2019 when Mr. Bradford stepped down as the CFO and took the position of CEO and accepted the associated employment agreement. During the six months ended March 31, 2020, the Company paid Blue Chip Accounting, LLC (“Blue Chip”) $55,199 for accounting, tax, administrative services and reimbursement for office supplies. Blue Chip is 50% beneficially owned by Mr. Bradford. Blue Chip performed all services at discounted rates and none of the charges were associated with work performed by Mr. Bradford. The services consisted of preparing and filing tax returns, bookkeeping, accounting and administrative support assistance. The Company also sub-leases office space from Blue Chip (see note 10 for additional details). During the six months ended March 31, 2020, $5,575 was paid to Blue Chip for rent. Bryan Huber – Former Officer and Director On August 28, 2018, the Company executed an agreement with Zero Positive, LLC an entity controlled by Mr. Huber. In accordance with the agreement with Zero Positive, LLC, Mr. Huber earned $125,154 and $85,209, during the six months ended March 31, 2020 and 2019. On March 12, 2019, the Agreement was terminated upon the execution of a separation agreement. All amounts owed from all agreements totaling $90,000 were paid in full. On September 28, 2018, in connection with the consulting agreement executed with Zero Positive, LLC, the Company issued warrants to purchase 90,000 shares of common stock at an exercise price of $8.00 per share to Zero Positive. The warrants were valued at $2,607,096 using the Black Scholes option pricing model based upon the following assumptions: term of 10 years, risk free interest rate of 3.05%, a dividend yield of 0% and volatility rate of 191%. The warrants vest as follows: 30,000 vested immediately, the balance vest evenly on the last day of each month over forty-two months beginning August 31, 2018. As of March 31, 2020, 54,286 warrants had vested, and the Company recorded an expense of $248,295 and 248,295 during the six months ended March 31, 2020 and 2019. Matthew Schultz- Chairman of the Board and Former Chief Executive Officer The Company has a consulting agreement with Matthew Schultz, our former Chief Executive Officer, for management services. In accordance with this agreement, as amended, Mr. Schultz earned $0 and $48,000, respectively during the six months ended March 31, 2020 and 2019. The agreement was terminated on October 7, 2019 when Mr. Schultz stepped down as the CEO and took the position of Chairman of the Board. Mr. Schultz received $126,000 as compensation for his services as chairman of the board during the six months ended March 31, 2020. The Company additionally entered into an agreement on November 15, 2019 with an organization to provide general investor relations and consulting services that Mr. Schultz is affiliated with. The Company paid the organization $49,500 in fees plus $176,000 in expense reimbursements for the six months ended March 31, 2020. The agreement was terminated in March 2020. Larry McNeill, Roger Beynon, Dr. Tom Wood –Directors Effective January 1, 2019, the Company agreed to pay non-executive independent board members $2,500 per month. Mr. McNeill earned $15,000 and $15,000 in Board compensation during the six months ended March 31, 2020 and 2019. Mr. Beynon and Dr. Wood each earned $15,000 and $0 in Board compensation during the six months ended March 31, 2020 and 2019.

STOCKHOLDERS' EQUITY

STOCKHOLDERS' EQUITY	6 Months Ended
	Mar. 31, 2020
Equity [Abstract]
STOCKHOLDERS' EQUITY	Overview The Company’s authorized capital stock consists of 20,000,000 shares of common stock and 10,000,000 shares of preferred stock, par value $0.001 per share. As of March 31, 2020, there were 5,745,415 shares of common stock issued and outstanding and 1,750,000 shares of preferred stock issued and outstanding. On December 10, 2019, the Financial Industry Regulatory Authority (“FINRA”) approved the Company’s 1:10 reverse stock split of the Company’s common stock. The reverse stock split took effect on December 11, 2019. Unless otherwise noted, impacted amounts and share information in the consolidated financial statements and notes thereto as of and for the periods ended March 31, 2020 and September 30, 2019, have been adjusted for the stock split as if such stock split occurred on the first day of the first period presented. Amendment to Articles of Incorporation On August 9, 2019, the Company filed a Certificate of Amendment to its Articles of Incorporation to increase its authorized shares of common stock from 100,000,000 to 200,000,000. The amendment was previously approved by written consent of the Company’s Board and more than a majority of the voting power of its stockholders and delivered to stockholders of record as of the close of business July 2, 2019 pursuant to a Definitive Information Statement on Schedule 14C. As a result of the reverse split mentioned above, the effect of the filed amendment reduced the authorized shares to 20,000,000. On October 4, 2019, pursuant to Article IV of our Articles of Incorporation, our Board of Directors voted to increase the number of shares of preferred stock designated as Series A Preferred Stock from one million (1,000,000) shares to two million (2,000,000) shares, par value $0.001. Under the Certificate of Designation, holders of Series A Preferred Stock will be entitled to quarterly dividends on 2% of our earnings before interest, taxes and amortization. The dividends are payable in cash or common stock. The holders will also have a liquidation preference on the state value of $0.02 per share plus any accumulated but unpaid dividends. The holders are further entitled to have us redeem their Series A Preferred Stock for three shares of common stock in the event of a change of control and they are entitled to vote together with the holders of our common stock on all matters submitted to shareholders at a rate of forty-five (45) votes for each share held. The rights of the holders of Series A Preferred Stock are defined in the relevant Amendment to the Certificate of Designation filed with the Nevada Secretary of State on October 9, 2019. Certificate of Preferred Stock Designation On April 16, 2019, pursuant to Article IV of our Articles of Incorporation, the Company’s Board of Directors voted to designate a class of preferred stock entitled Series B Preferred Stock, consisting of up to one hundred thousand (100,000) shares, par value $0.001. Under the Certificate of Designation, the holders of Series B Preferred Stock are entitled to the following powers, designations, preferences and relative participating, optional and other special rights, and the following qualifications, limitations and restrictions, among others as set forth in the Certificate of Designation: § The holders of shares of Series B Preferred Stock will have no right to vote on any matters, questions or proceedings of the Company including, without limitation, the election of directors; § Commencing on the date of issuance, the Series B Preferred Stock will accrue cumulative in kind accruals (“the Accruals”) at the rate of 7.5% per annum; § Upon any liquidation, dissolution or winding up of the Company, the holders of the Series B Preferred Stock will be entitled to be paid out of the assets of the Company available for distribution to its stockholders an amount with respect to each share of Series B Preferred Stock equal to $5,000.00 (the “Face Value”), plus an amount equal to any accrued but unpaid Accruals thereon (the “Liquidation Value”); § On maturity, the Company may redeem the Series B Preferred Stock by paying the holder the Liquidation Value; § Before maturity, the Company may redeem the Series B Preferred stock on 30 days’ notice by paying 145% of the outstanding Face Value per share; § If the Company determines to liquidate, dissolve or wind-up its business and affairs, the Company will, within three trading days of such determination and prior to effectuating any such action, redeem all outstanding shares of Series B Preferred Stock; § In the event of a conversion of any shares of Series B Preferred Stock, the Company will (a) satisfy the payment of the Conversion Premium, which is defined as the Face Value of the shares converted multiplied by the product of 7.5% and the number of whole years between issuance and maturity, and (b) issue to the holder of the shares of Series B Preferred Stock a number of conversion shares equal to the Face Value divided by the applicable Conversion Price (defined as 90% of the of the 5 lowest individual daily volume weighted average prices of the Common Stock from issuance to conversion less $0.75 per share, but no less than the Floor Price ($3.50) with respect to the number of shares converted; While the note is outstanding if Triggering Events occur the conversion rate may be decreased by 10% and the interest rate increased by 10% for each Triggering Event. In the event of certain defaults, conversion price may not be subject to a floor. § if at any time the Company grants, issues or sells any options, convertible securities or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any class of shares of Common Stock (the “Purchase Rights”), then holder will be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which holder could have acquired if holder had held the number of shares of Common Stock acquirable upon conversion of Series B Preferred Stock; § At maturity (2 years from issuance), all outstanding shares of Series B Preferred Stock shall automatically convert into common stock at the Conversion Price; and ▪ At no time may the holders of Series B Preferred Stock own more than 4.99% of the outstanding common stock in the Company. On March 6, 2020, the Company withdrew the Certificate of Designation for the Series B Preferred Stock. At the time of withdrawal, no shares of Series B Preferred Stock were issued and outstanding. Common Stock issuances during the six months ended March 31, 2020 The Company issued 997,605 shares of common stock in accordance with the terms of the convertible debt agreement due to the decrease in stock price. (See Note 9 for additional details.) The Company issued 2,000 shares of common stock for services rendered to an independent consultant. The Company issued 793 shares of common stock as a result of rounding related to the reverse stock split. The Company issued 95,699 shares of common stock in relation to the acquisition of p2k (See note 3 for additional details.) Common stock returned during the six months ended March 31, 2020 As a result of a note payoff on December 5, 2019, 5,000 shares common stock were returned to treasury and cancelled on January 13, 2020. As a result of the cancellation of an investor relations services contract, 25,000 shares were returned to treasury and cancelled on February 10, 2020. Series A Preferred Stock issuances during the six months ended March 31, 2020 On October 4, 2019, the Company authorized the issuance of a total of seven hundred and fifty thousand (750,000) shares of its designated Series A Preferred Stock to members of its board of directors for services rendered. A fair value of $0.02 per share was determined by the Company. Director fees of $15,000 was recorded as a result of the stock issued. Common Stock issuances during the six months ended March 31, 2019 During the period commencing October 1, 2018 through March 31, 2019, the Company received $361,800 from 14 investors pursuant to private placement agreements with the investors to purchase 45,225 shares of the Company’s common stock at a purchase price equal to $8.00 for each share of common stock. On September 11, 2018, the Company entered into an agreement with Regal Consulting, LLC for investor relations services. Under this agreement the Company agreed to issue 3,000 shares of the Company’s common stock per month as compensation for services plus additional cash compensation. During the six months ended March 31, 2019, the Company issued a total of 18,000 shares of its common stock in accordance with the agreement. Stock compensation of $531,600 was recorded as a result of the stock issued under the agreement. On October 15, 2018, the Company entered into an agreement with a consultant for services. Under this agreement the Company agreed to issue 3,000 shares of the Company’s common stock which vest evenly over a six-month period from the agreement date. During the six months ended March 31, 2019, the Company recorded stock compensation of $68,819 was recorded as a result of the stock issued under the agreement. On October 2, 2018, an investor exercised warrants to purchase 300 shares of the Company’s $0.001 par value common stock at a purchase price equal to $3.63 for each share of Common stock. The Company receive $1,088 as a result of this exercise. The Company issued 10,000 shares in relation to a Securities purchase agreement executed on December 31, 2018. (See Note 8 for additional details.) On December 31, 2018, the Company settled $25,000 of a promissory note through the issuance of 2,500 shares of the Company’s common stock. The shares were valued at $51,225 and a $26,225 loss on settlement of debt was recorded as a result of the issuance. On January 7, 2019, a total of 144,417 shares of the Company’s common stock were issued in connection with the cashless exercise of 150,000 common stock warrants at an exercise price of $0.83. On January 7, 2019, an investor converted $2,500,000 in principal and $875,000 in interest as a conversion premium, for 178,472 shares of the Company’s common stock at an effective conversion price of $18.90. On January 22, 2019, in accordance with a merger agreement, the Company issued 175,000 shares of the Company’s common stock. On February 26, 2019, a total of 24,628 shares of the Company’s common stock were issued in connection with the cashless exercise of 25,000 common stock warrants at an exercise price of $0.83. On March 6, 2019, the investor converted $1,000,000 in principal and $350,000 in interest as a conversion premium, for 71,389 shares of the Company’s common stock at an effective conversion price of $18.90. On March 26, 2019, a total of 48,857 shares of the Company’s common stock were issued in connection with the cashless exercise of 50,000 common stock warrants at an exercise price of $0.83. Common stock returned during the six months ended March 31, 2019 As a result of a conversion of a note on September 21, 2018, 13,750 shares common stock were returned to treasury and cancelled on December 21, 2018. As a result of a note payoff on January 3, 2019, 13,750 shares of common stock were returned to treasury and cancelled on January 8, 2019.

STOCK WARRANTS

STOCK WARRANTS	6 Months Ended
	Mar. 31, 2020
Accounting Policies [Abstract]
STOCK WARRANTS	The following is a summary of stock warrant activity during the six months ended March 31, 2020. Number of Warrant Shares Weighted Average Exercise Price Balance, September 30, 2019 1,314,063 $ 21.62 Warrants granted — $ — Warrants expired — — Warrants canceled — — Warrants exercised — — Balance, March 31, 2020 1,314,063 $ 21.62 As of March 31, 2020, the outstanding warrants have a weighted average remaining term of was 2.40 years and an intrinsic value of $88,500. As of March 31, 2020, there are warrants exercisable to purchase 1,282,636 shares of common stock in the Company and 31,429 unvested warrants outstanding that cannot be exercised until vesting conditions are met. 996,198 of the warrants require a cash investment to exercise as follows, 5,000 required a cash investment of $8.00 per share, 449,865 require a cash investment of $15.00 per share, 125,000 require a cash investment of $20.00 per share, 103,000 require a cash investment of $25.00 per share, 200,000 require an investment of $35.00 per share, 10,000 require an investment of $40.00 per share, 60,000 require an investment of $50.00 per share, 38,333 require a cash investment of $75.00 per share and 5,000 require a cash investment of $100.00 per share. 317,865 of the outstanding warrants contain provisions allowing a cashless exercise at their respective exercise prices. Warrant activity for the six months ended March 31, 2019 On October 15, 2018, the Company entered into an agreement with a consultant for services. Under this agreement the Company agreed to issue 3,000 warrants to purchase shares of the Company’s common stock at an exercise price of $25.00 for a period of five years which vest evenly over a six-month period from the agreement date. During the six months ended March 31, 2020 and 2019 the Company recorded stock compensation of $0 and $68,643 as a result of the stock issued under the agreement. The warrants were valued using the black-Scholes valuation model. On December 31, 2018, in connection with a Securities purchase agreement (see Note 9 for additional details) the Company issued Common Stock Purchase Warrants to acquire up to 308,333 shares of common stock for a term of three years on a cash-only basis at an exercise price of $20.00 per share with respect to 125,000 Warrant Shares, $25.00 with respect to 100,000 Warrant Shares, $50.00 with respect to 50,000 Warrant Shares and $75.00 with respect to 33,333 Warrant Shares. On August 28, 2018, in connection with the Consulting agreement executed with Zero Positive, LLC the Company issued warrants to purchase 90,000 shares of common stock at an exercise price of $8.00 per share to Zero Positive. The warrants were valued at $2,607,096 using the Black Scholes option pricing model. The warrants vest as follows: 30,000 warrants vested immediately, the balance vest evenly on the last day of each month over the forty-two months beginning August 31, 2018. As of March 31, 2020, 58,571 warrants had vested, and the Company recorded an expense of $248,295 and 248,295 during the six months ended March 31, 2020 and 2019. (See Note 9 for additional details.) On January 22, 2019, in accordance with a merger agreement, CleanSpark issued; a five-year warrant to purchase 50,000 shares of CleanSpark common stock at an exercise price of $16.00 per share, and a five-year warrant to purchase 50,000 shares of CleanSpark common stock at an exercise price of $20.00 per share. The warrants were valued at $1,102,417 and $1,102,107, respectively. The Black-Scholes model utilized the following inputs to value the warrants granted during the six months ended March 31, 2019: Fair value assumptions – Warrants: March 31, 2019 Risk free interest rate 2.46% -3.01% Expected term (years) 3-5 Expected volatility 265-268% Expected dividends 0% On January 7, 2019, a total of 144,417 shares of the Company’s common stock were issued in connection with the cashless exercise of 150,000 common stock warrants at an exercise price of $0.83. On February 26, 2019, a total of 24,628 shares of the Company’s common stock were issued in connection with the cashless exercise of 25,000 common stock warrants at an exercise price of $0.83. On March 26, 2019, a total of 48,857 shares of the Company’s common stock were issued in connection with the cashless exercise of 50,000 common stock warrants at an exercise price of $0.83. As of March 31, 2020, the Company expects to recognize $910,415 of stock-based compensation for the non-vested outstanding warrants over a weighted-average period of 1.8 years.

STOCK OPTIONS

STOCK OPTIONS	6 Months Ended
	Mar. 31, 2020
Other Liabilities Disclosure [Abstract]
STOCK OPTIONS	The Company sponsors a stock-based incentive compensation plan known as the 2017 Incentive Plan (the “Plan”), which was established by the Board of Directors of the Company on June 19, 2017. A total of 300,000 shares were initially reserved for issuance under the Plan. As of March 31, 2020, there were 10,513 shares available for issuance under the plan. The Plan allows the Company to grant incentive stock options, non-qualified stock options, stock appreciation right, or restricted stock. The incentive stock options are exercisable for up to ten years, at an option price per share not less than the fair market value on the date the option is granted. The incentive stock options are limited to persons who who The following is a summary of stock option activity during the six months ended March 31, 2020. Number of Option Shares Weighted Average Exercise Price Balance, September 30, 2019 81,254 $ 11.82 Options granted 233,233 $ 5.28 Options expired 25,000 8.00 Options cancelled — — Options exercised — — Balance, March 31, 2020 289,487 $ 6.88 As of March 31, 2020, there are options exercisable to purchase 261,577 shares of common stock in the Company. As of March 31, 2020, the outstanding options have a weighted average remaining term of was 2.49 years and an intrinsic value of $0. Option activity for the six months ended March 31, 2020 During the six months ended March 31, 2020, the Company issued 233,233 options to purchase shares of common stock to employees, the shares were granted at quoted market prices ranging from $4.50 to $8.50. The options were valued at issuance using the Black Scholes model and stock compensation expense of $716,740 was recorded as a result of the issuances. The Black-Scholes model utilized the following inputs to value the options granted during the six months ended March 31, 2020: Fair value assumptions – Options: March 31, 2020 Risk free interest rate 0.85-1.73% Expected term (years) 3-5 Expected volatility 124%-209% Expected dividends 0% As of March 31, 2020, the Company expects to recognize $291,084 of stock-based compensation for the non- vested outstanding options over a weighted-average period of 2.54 years. Option activity for the six months ended March 31, 2019 During the six months ended March 31, 2019, the Company issued 11,737 options to purchase shares of common stock to employees, the shares were granted at quoted market prices ranging from $15.10 to $59.00. The options were valued at issuance using the Black Scholes model and stock compensation expense of $220,000 was recorded as a result of the issuances. On March 10, 2018 the Company issued a total of 25,000 options to four consultants for advisory services. The options vest evenly 12 months from issuance. The options expire 24 months after issuance and require a cash investment to exercise. The options were valued at issuance using the Black Scholes model at $342,500 and amortized of the term of the agreement. During the six months ended March 31, 2019, $191,425 was expensed as stock-based compensation. The Black-Scholes model utilized the following inputs to value the options granted during the six months ended March 31, 2019: Fair value assumptions – Options: March 31, 2019 Risk free interest rate 2.21-2.91% Expected term (years) 3 Expected volatility 256%-271% Expected dividends 0%

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	6 Months Ended
	Mar. 31, 2020
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	Office leases Utah Corporate Office On November 22, 2019, the company entered into a lease to relocate the corporate office to 1185 South 1800 West, Suite 3, Woods Cross, UT 84047. The agreement calls for the Company to make payments of $2,300 in base rent per month through February 28, 2021. The lease term is on an annual basis beginning on March 1, 2020. San Diego Office On May 15, 2018, the Company executed a 37-month lease agreement, which commenced on July 1, 2018 at 4360 Viewridge Avenue, Suite C, San Diego, California. The agreement calls for the Company to make payments of $4,057 in base rent per month through July 31, 2021 subject to an annual 3% rent escalation. Future minimum Fiscal year ending (six months remaining) September 30, 2020 $25,448 Fiscal year ending September 30, 2021 $43,170 Las Vegas Offices On January 2, 2020, the Company entered into a sublease agreement for office space at 8475 S. Eastern Ave., Suite 200, Las Vegas, NV 89123. The agreement calls for the Company to make monthly payments of $1,575 in base rent through January 1, 2021. The lease term is on an annual basis beginning January 2, 2020. The Company assumed p2k’s lease agreement entered into on October 17, 2017 at 7955 W. Badura Ave., Suite 1040, Las Vegas, NV 89113. The agreement calls for $1,801 in base rent through October 31, 2020. The lease expires on October 31, 2020. The Company does not expect to renew. Legal contingencies From time to time we may be subject to litigation. Risks associated with legal liability are difficult to assess and quantify, and their existence and magnitude can remain unknown for significant periods of time. We have acquired liability insurance to reduce such risk exposure to the Company. Despite the measures taken, such policies may not cover future litigation, or the damages claimed may exceed our coverage which could result in continent liabilities.

MAJOR CUSTOMERS AND VENDORS

MAJOR CUSTOMERS AND VENDORS	6 Months Ended
	Mar. 31, 2020
Notes to Financial Statements
MAJOR CUSTOMERS AND VENDORS	For the six months ended March 31, 2020 and 2019, the Company had the following customers that represented more than 10% of sales. March 31, 2020 March 31, 2019 Customer A 55.5 % 35.8% Customer B 24.4 % — Customer C — 44% Customer D — 14.2% For the six months ended March 31, 2020 and 2019, the Company had the following suppliers that represented more than 10% of direct material costs. Internally developed product costs and labor for services rendered are excluded from the calculation. March 31, 2020 March 31, 2019 Vendor A 92.27 % 83.1%

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	6 Months Ended
	Mar. 31, 2020
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	COVID-19 Joint Venture On April 6, 2020, the Company entered into a joint venture agreement with international partners to procure, distribute and supply masks, gowns, gloves, and other Personal Protective Equipment (PPE) to be supplied to hospitals and frontline medical personnel. The agreement is effective until December 31, 2020, unless otherwise extended by unanimous consent of the members of the joint venture, including the Company. The Manager of the joint venture, which is not the Company or its affiliates, will have the duty to manage the day-to-day business of the joint venture, monitor the financial, business and operational affairs of the joint venture and take all responsibilities related to the procurement and delivery of products and related matters. The Company contributed the necessary capital in the amount of $660,000 on April 6, 2020 to assist with the importation of these products into the United States, with the potential for additional monies to be lent by the Company to the joint venture, upon mutual consent if necessary. Conversion of convertible promissory notes On April 8, 2020, in accordance with the terms of the December 31, 2018 Securities Purchase Agreement, the Investor was issued an additional 172,400 shares of common stock due to the decrease in stock price resulting in an effective conversion price of $1.50. (see note 9 for additional details) On April 9, 2020, in accordance with the terms of the December 31, 2018 Securities Purchase Agreement, the Investor was issued an additional 794,308 shares of common stock due to the decrease in stock price resulting in an effective conversion price of $1.50. (see note 9 for additional details) On April 15, 2020, in connection with December 31, 2018 Securities Purchase Agreement, the Investor converted $1,250,000 in principal and $437,500 in interest as a conversion premium, for 1,125,000 shares of the Company’s common stock at an effective conversion price of $1.50 due to a trigger event for the Company not filing its annual report on Form 10-K for the fiscal year ended September 30, 2018 on or before December 31, 2018. (see note 9 for additional details) On May 5, 2020, in connection with the Securities Purchase Agreement dated April 17, 2019, the investor converted $750,000 in principal and $112,500 in interest as a conversion premium for 575,000 shares of the Company’s common stock at an effective conversion price of $1.50. (see note 9 for additional details) On May 6, 2020, in connection with the Securities Purchase Agreement dated April 17, 2019, the investor converted $600,000 in principal and $90,000 in interest as a conversion premium for 460,000 shares of the Company’s common stock at an effective conversion price of $1.50. (see note 9 for additional details) On May 7, 2020, in connection with the Securities Purchase Agreement dated April 17, 2019, the investor converted $595,000 in principal and $87,250 in interest as a conversion premium for 456,167 shares of the Company’s common stock at an effective conversion price of $1.50. (see note 9 for additional details) On May 8, 2020, in connection with the Securities Purchase Agreement dated April 17, 2019, the investor converted $350,000 in principal and $52,500 in interest as a conversion premium for 268,333 shares of the Company’s common stock at an effective conversion price of $1.50. (see note 9 for additional details) On May 11, 2020, in connection with the Securities Purchase Agreement dated April 17, 2019, the investor converted $350,000 in principal and $52,500 in interest as a conversion premium for 268,333 shares of the Company’s common stock at an effective conversion price of $1.50. (see note 9 for additional details) Amendment of convertible promissory notes On May 1, 2020, the Company entered into a third amendment (the “Third Amendment”) with the Investor. The Third Amendment amended the Securities Purchase Agreements and Debentures dated December 31, 2018 and April 17, 2019 that were previously amended on March 4, 2020 and March 13, 2020. As provided in the Third Amendment, the Company will not be required to reserve or issue to Investor more shares of Common Stock than were reserved for Investor prior to the Amendment Date until September 29, 2020. In addition, the Company previously amended the Agreement to lower the Closing Price of the Common Stock which may trigger an Event of Default from $5.00 per share under the Agreements down to $1.75 per share for 5 consecutive Trading Days after June 11, 2020. The Third Amendment further amended this clause in the Agreements to provide that an Event of Default under this provision would not be triggered, if at all, until after September 29, 2020.

SUMMARY OF SIGNIFICANT POLICI_2

SUMMARY OF SIGNIFICANT POLICIES (Policies)	6 Months Ended
	Mar. 31, 2020
Accounting Policies [Abstract]
Basis of presentation and liquidity	The accompanying unaudited interim financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America and the rules of the Securities and Exchange Commission, and should be read in conjunction with the audited financial statements and notes thereto contained in the Company’s most recent Annual Financial Statements filed with the SEC on Form 10-K. In the opinion of management, all adjustments, consisting of normal recurring adjustments, necessary for a fair presentation of financial position and the results of operations for the interim period presented have been reflected herein. The results of operations for the interim period are not necessarily indicative of the results to be expected for the full year. Notes to the financial statements which would substantially duplicate the disclosures contained in the audited financial statements for the most recent fiscal period, as reported in the Form 10-K, have been omitted. The Company has incurred losses for the past several years while developing infrastructure and its software platforms. As shown in the accompanying unaudited consolidated financial statements, the Company incurred net losses of $7,731,352 during the six months ended March 31, 2020. In response to these conditions and to ensure the Company has sufficient capital for ongoing operations for a minimum we
Principles of Consolidation	The accompanying consolidated financial statements include the accounts of CleanSpark, Inc., and its wholly owned operating subsidiaries, CleanSpark, LLC, CleanSpark, II, LLC, CleanSpark Critical Power Systems Inc. and p2kLabs, Inc. All material intercompany transactions have been eliminated upon consolidation of these entities.
Use of Estimates	Use of estimates
Cash and cash equivalents	Cash and cash equivalents
Revenue recognition	Revenue Recognition • Identification of the contract, or contracts, with a customer • Identification of the performance obligations in the contract • Determination of the transaction price • Allocation of the transaction price to the performance obligations in the contract • Recognition of revenue when, or as, the Company satisfies a performance obligation Engineering, Service & Installation or Construction Contracts The Company recognizes engineering and construction contract revenue over time, as performance obligations are satisfied, due to the continuous transfer of control to the customer. Engineering and construction contracts are generally accounted for as a single unit of account (a single performance obligation) and are not segmented between types of services. The Company recognizes revenue based primarily on contract cost incurred to date compared to total estimated contract cost (an input method). The input method is the most faithful depiction of the Company’s performance because it directly measures the value of the services transferred to the customer. Customer-furnished materials, labor and equipment and, in certain cases, subcontractor materials, labor and equipment, are included in revenue and cost of revenue when management believes that the company is acting as a principal rather than as an agent (i.e., the company integrates the materials, labor and equipment into the deliverables promised to the customer). Customer-furnished materials are only included in revenue and cost when the contract includes construction activity and the Company has visibility into the amount the customer is paying for the materials or there is a reasonable basis for estimating the amount. The Company recognizes revenue, but not profit, on certain uninstalled materials that are not specifically produced, fabricated, or constructed for a project. Revenue on these uninstalled materials is recognized when the cost is incurred (when control is transferred). Changes to total estimated contract cost or losses, if any, are recognized in the period in which they are determined as assessed at the contract level. Pre-contract costs are expensed as incurred unless they are expected to be recovered from the client. Project mobilization costs are generally charged to project costs as incurred when they are an integrated part of the performance obligation being transferred to the client. Customer payments on engineering and construction contracts are typically due within 30 to 45 days of billing, depending on the contract. For service contracts (including maintenance contracts) in which the Company has the right to consideration from the customer in an amount that corresponds directly with the value to the customer of the Company’s performance completed to date, revenue is recognized when services are performed and contractually billable. Service contracts that include multiple performance obligations are segmented between types of services. For contracts with multiple performance obligations, the Company allocates the transaction price to each performance obligation using an estimate of the stand-alone selling price of each distinct service in the contract. Revenue recognized on service contracts that have not been billed to clients is classified as a current asset under contract assets on the Consolidated Balance Sheets. Amounts billed to clients in excess of revenue recognized on service contracts to date are classified as a current liability under contract liabilities. Customer payments on service contracts are typically due within 30 days of billing, depending on the contract. Revenues from Sale of Equipment Performance Obligations Satisfied at a point in time. We recognize revenue on agreements for non-customized equipment we sell on a standardized basis to the market at a point in time. We recognize revenue at the point in time that the customer obtains control of the good, which is generally upon shipment or when the customer has physical possession of the product depending on contract terms. We use proof of delivery for certain large equipment with more complex logistics, whereas the delivery of other equipment is estimated based on historical averages of in-transit periods (i.e., time between shipment and delivery). In situations where arrangements include customer acceptance provisions based on seller or customer-specified objective criteria, we recognize revenue when we have concluded that the customer has control of the goods and that acceptance is likely to occur. We generally do not provide for anticipated losses on point in time transactions prior to transferring control of the equipment to the customer. Our billing terms for these point in time equipment contracts vary and generally coincide with shipment to the customer; however, within certain businesses, we receive progress payments from customers for large equipment purchases, which is generally to reserve production slots with our manufacturing partners, which are recorded as contract liabilities. Service Performance obligations satisfied over time. We enter into long-term product service agreements with our customers primarily within our microgrid segment. These agreements require us to provide preventative maintenance, and standby support services that include certain levels of assurance regarding system performance throughout the contract periods, these contracts will generally range from 1 to 10 years. We account for items that are integral to the maintenance of the equipment as part of our service-related performance obligation, unless the customer has a substantive right to make a separate purchasing decision (e.g., equipment upgrade). Contract modifications that extend or revise contract terms are not uncommon and generally result in our recognizing the impact of the revised terms prospectively over the remaining life of the modified contract (i.e., effectively like a new contract). Revenues are recognized for these arrangements on a straight-line basis consistent with the nature, timing and extent of our services, which primarily relate to routine maintenance and as needed product repairs. Our billing terms for these contracts vary, but we generally invoice periodically as services are provided. Contract assets represent revenue recognized in excess of amounts billed and include unbilled receivables (typically for cost reimbursable contracts) of $0 and contract work in progress (typically for fixed-price contracts) of $4,282 and $57,077 as of March 31, 2020 and September 30, 2019, respectively. Unbilled receivables, which represent an unconditional right to payment subject only to the passage of time, are reclassified to accounts receivable when they are billed under the terms of the contract. Advances that are payments on account of contract assets of $611,000 and $360,000 as of March 31, 2020 and September 30, 2019, respectively, have been deducted from contract assets. Contract liabilities represent amounts billed to clients in excess of revenue recognized to date. The Company recorded $590,241 and $499,401 in contract liabilities as of March 31, 2020 and September 30, 2019, respectively. Revenues from software The Company derives its revenue from subscription fees from customers for access to its mVSO platform. The Company’s policy is to exclude sales and other indirect taxes when measuring the transaction price of its subscription agreements. The Company’s subscription agreements generally have monthly or annual contractual terms. Revenue is recognized ratably over the related contractual term beginning on the date that the platform is made available to a customer. Access to the platform represents a series of distinct services as the Company continually provides access to, and fulfills its obligation to the end customer over the subscription term. The series of distinct services represents a single performance obligation that is satisfied over time. Revenues from design, software development and other technology-based consulting services For service contracts performed under Master Services Agreements (“MSA”) and accompanying Statement(s) of Work (“SOW”), revenue is recognized based on the performance obligation(s) outlined in the SOW which is typically hours worked or specific deliverable milestones. In the case of a milestone-based SOW, the Company recognizes revenues as each deliverable is signed off by the customer. Variable Consideration The nature of the Company’s contracts gives rise to several types of variable consideration, including claims and unpriced change orders; awards and incentive fees; and liquidated damages and penalties. The Company recognizes revenue for variable consideration when it is probable that a significant reversal in the amount of cumulative revenue recognized will not occur. The Company estimates the amount of revenue to be recognized on variable consideration using the expected value (i.e., the sum of a probability-weighted amount) or the most likely amount method, whichever is expected to better predict the amount. Factors considered in determining whether revenue associated with claims (including change orders in dispute and unapproved change orders in regard to both scope and price) should be recognized include the following: (a) the contract or other evidence provides a legal basis for the claim, (b) additional costs were caused by circumstances that were unforeseen at the contract date and not the result of deficiencies in the company’s performance, (c) claim-related costs are identifiable and considered reasonable in view of the work performed, and (d) evidence supporting the claim is objective and verifiable. If the requirements for recognizing revenue for claims or unapproved change orders are met, revenue is recorded only when the costs associated with the claims or unapproved change orders have been incurred. Back charges to suppliers or subcontractors are recognized as a reduction of cost when it is determined that recovery of such cost is probable, and the amounts can be reliably estimated. Disputed back charges are recognized when the same requirements described above for claims accounting have been satisfied. The C Practical Expedients If the company has a right to consideration from a customer in an amount that corresponds directly with the value of the company’s performance completed to date (a service contract in which the company bills a fixed amount for each hour of service provided), the company recognizes revenue in the amount to which it has a right to invoice for services performed. The company does not adjust the contract price for the effects of a significant financing component if the company expects, at contract inception, that the period between when the company transfers a service to a customer and when the customer pays for that service will be one year or less. The company has made an accounting policy election to exclude from the measurement of the transaction price all taxes assessed by governmental authorities that are collected by the company from its customers (use taxes, value added taxes, some excise taxes). For the six months ended March 31, 2020 and 2019, the Company reported revenues of $4,635,107 and $986,806, respectively.
Accounts Receivable	Accounts receivable and $254,570 at March 31, 2020, and September 30, 2019, respectively. Retention receivable is the amount withheld by a customer until a contract is completed. Retention receivables of $158,300 and $159,989 were included in the balance of trade accounts receivable as of March 31, 2020 and September 30, 2019, respectively.
Investment Securities	Investment securities Interest income is recognized based on the coupon rate and increased by accretion of discounts earned or decreased by the amortization of premiums paid over the contractual life of the security. For individual debt securities where the Company either intends to sell the security or more likely than not will not recover all of its amortized cost, the OTTI is recognized in earnings equal to the entire difference between the security's cost basis and its fair value at the balance sheet date. For individual debt securities for which a credit loss has been recognized in earnings, interest accruals and amortization and accretion of premiums and discounts are suspended when the credit loss is recognized. Interest received after accruals have been suspended is recognized in income on a cash basis. The Company holds investments in both publicly held and privately held equity securities. Privately held equity securities are recorded at cost and adjusted for observable transactions for same or similar investments of the issuer (referred to as the measurement alternative) or impairment. All gains and losses on privately held equity securities, realized or unrealized, are recorded through gains or losses on equity securities on the consolidated statement of operations. Publicly held equity securities are based on fair value accounting with unrealized gains or losses resulting from changes in fair value reflected as unrealized gains or losses on equity securities in our consolidated statement of operations.
Stock-based compensation	Stock-based compensation Compensation-Stock Compensation, received in exchange for an award of an equity instrument based on the grant-date fair value of the award. Stock-based compensation expense is recognized on a straight-line basis over the requisite service period. The Company may issue compensatory shares for services including, but not limited to, executive, management, accounting, operations, corporate communication, financial and administrative consulting services.
Earnings (loss) per share	Earnings (loss) per share Earnings Per Share, shares issuable upon exercise of outstanding options, warrants and convertible debt which have been excluded as anti-dilutive.
Warranty Liability	Warranty Liability
Recently Issued Accounting Pronouncements	Recently issued accounting pronouncements In June 2018, the FASB issued ASU 2018-07, "Compensation-Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting," which modifies the accounting for share-based payment awards issued to nonemployees to largely align it with the accounting for share-based payment awards issued to employees. ASU 2018-07 is effective for us for annual periods beginning October 1, 2019. The new standard did not have a material impact on the Company’s results of operations or cash flows. In August 2018, the FASB issued ASU 2018-15, "Intangibles-Goodwill and Other-Internal-Use Software (Subtopic 350-40): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract," which allows for the capitalization of certain implementation costs incurred in a hosting arrangement that is a service contract. ASU 2018-15 allows for either retrospective adoption or prospective adoption to all implementation costs incurred after the date of adoption. ASU 2018-15 is effective for fiscal years beginning after December 15, 2019. We are currently evaluating the impact the adoption of this new standard will have on our financial position and results of operations. In February 2016, the FASB issued guidance within ASU 2016-02, Leases Leases Leases (Topic 842) Targeted Improvements continue to apply the legacy guidance in ASC 840, Leases In January, 2017 the FASB issued guidance within ASU 2017-01, Business Combinations. The amendments in ASU 2017-01 Clarify the definition of a business by providing a framework to use in determining when a set of assets is a business. ASU 2017-01 is effective for us for annual periods beginning October 1, 2019. The new standard did not have a material impact on the Company’s results of operations or cash flows. In January, 2017 the FASB issued guidance within ASU 2017-04, Intangibles-Goodwill and Other. The amendments in ASU 2017-04 simplify the subsequent measurement of goodwill by comparing the fair value of a reporting unit with its carrying amount. ASU 2017-04 is effective for fiscal years beginning after December 15, 2019. We are currently evaluating the impact the adoption of this new standard will have on our financial position and results of operations. The Company has evaluated all other recent accounting pronouncements, and believes that none of them will have a material effect on the Company's financial position, results of operations or cash flows.
Concentration Risk	Concentration Risk At times throughout the year, the Company may maintain cash balances in certain bank accounts in excess of FDIC limits. As of March 31, 2020, the cash balance in excess of the FDIC limits was $4,256,510. The Company has not experienced any losses in such accounts and believes it is not exposed to any significant credit risk in these accounts. The Company had certain customers whose revenue individually represented 10% or more of the Company’s total revenue. (See Note 14 for details.)
Fair-value of financial instruments and derivative asset	Fair value of financial instruments and derivative asset Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value maximize the use of observable inputs and minimize the use of unobservable inputs. The Company utilizes a fair value hierarchy based on three levels of inputs, of which the first two are considered observable and the last unobservable. • Level 1 Quoted prices in active markets for identical assets or liabilities. These are typically obtained from real-time quotes for transactions in active exchange markets involving identical assets. • Level 2 Quoted prices for similar assets and liabilities in active markets; quoted prices included for identical or similar assets and liabilities that are not active; and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets. These are typically obtained from readily-available pricing sources for comparable instruments. • Level 3 Unobservable inputs, where there is little or no market activity for the asset or liability. These inputs reflect the reporting entity’s own beliefs about the assumptions that market participants would use in pricing the asset or liability, based on the best information available in the circumstances. The following table presents the Company’s financial instruments that are measured and recorded at fair value on the Company’s balance sh eets on a recurring basis, and their level within the fair value hierarchy as of March 31, 2020: Amount Level 1 Level 2 Level 3 Derivative asset $ 824,891 $ — $ — $ 824,891 Investment in equity security 252,000 252,000 — $ — Investment debt security 456,744 — — 456,744 Total $ 1,533,635 $ 252,000 $ — $ 1,281,635 The below table presents the change in the fair value of the derivative asset and investment in debt security during the six months ended March 31, 2020: Amount Balance at September 30, 2019 $ — Fair value at issuance, net of premium 456,744 Gain on derivative asset 824,891 Total $ 1,281,635
Reclassifications	Reclassifications

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Fair Value of Financial Instruments (Tables)	6 Months Ended
	Mar. 31, 2020
Accounting Policies [Abstract]
Fair value of financial instruments	Amount Level 1 Level 2 Level 3 Derivative asset $ 824,891 $ — $ — $ 824,891 Investment in equity security 252,000 252,000 — $ — Investment debt security 456,744 — — 456,744 Total $ 1,533,635 $ 252,000 $ — $ 1,281,635
Fair value of derivative asset and investment in debt security	Amount Balance at September 30, 2019 $ — Fair value at issuance, net of premium 456,744 Gain on derivative asset 824,891 Balance at March 31, 2020 $ 1,281,635

ACQUISITION OF P2K LABS, INC. (

ACQUISITION OF P2K LABS, INC. (Tables)	6 Months Ended
	Mar. 31, 2020
Accounting Policies [Abstract]
Fair value consideration	Consideration: Fair Value Cash $ 1,155,000 95,699 shares of common stock $ 445,000 26,950 common stock options $ 88,935 Total Consideration $ 1,688,935
Purchase price allocation	Purchase Price Allocation: Customer list $ 1,045,000 Design and other assets $ 123,000 Goodwill $ 642,388 Other assets and liabilities assumed, net $ (121,453) Total $ 1,688,935
Pro forma information	For the Three Months Ended For the Six Months Ended March 31, 2020 March 31, 2019 March 31, 2020 March 31, 2019 Net sales $ 3,716,725 $ 924,906 $ 5,006,806 $ 1,409,906 Net loss $ (5,970,217 ) $ (7,770,325 ) $ (7,851,673 ) $ (10,044,709) Loss per common share - basic and diluted $ (1.15 ) $ (1.84 ) $ (1.56 ) $ (2.52) Weighted average common shares outstanding - basic and diluted 5,188,384 4,217,662 5,031,749 3,980,517

INVESTMENTS IN INTERNATIONAL _2

INVESTMENTS IN INTERNATIONAL LAND ALLIANCE (Tables)	6 Months Ended
	Mar. 31, 2020
Schedule of Investments [Abstract]
Fair value assumptions	Fair value assumptions: March 31, 2020 Risk free interest rate 0.17% Expected term (months) 4 Expected volatility 152% Expected dividends 0%

CAPITALIZED SOFTWARE (Tables)

CAPITALIZED SOFTWARE (Tables)	6 Months Ended
	Mar. 31, 2020
Fair Value Disclosures [Abstract]
Capitalized Software	March 31, 2020 September 30, 2019 mVSO software $ 437,136 $ 352,211 mPulse software 741,846 741,846 Capitalized Software: 1,178,982 1,094,057 Less: accumulated amortization (118,565 ) (38,860) Capitalized Software, net $ 1,060,417 $ 1,055,197

INTANGIBLE ASSETS (Tables)

INTANGIBLE ASSETS (Tables)	6 Months Ended
	Mar. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Intangible Assets	March 31, 2020 September 30, 2019 Patents $ 74,112 $ 74,112 Websites 8,115 16,482 Customer list and non-compete agreement 6,767,024 5,722,024 Design assets $ 123,000 — Trademarks 5,928 5,928 Trade secrets 4,370,269 4,370,269 Intangible assets: 11,348,448 10,188,815 Less: accumulated amortization (4,019,659 ) (2,758,733) Intangible assets, net $ 7,328,789 $ 7,430,082

FIXED ASSETS (Tables)

FIXED ASSETS (Tables)	6 Months Ended
	Mar. 31, 2020
Property, Plant and Equipment [Abstract]
Schedule of Fixed Assets	March 31, 2020 September 30, 2019 Machinery and equipment $ 201,856 $ 212,082 Leasehold improvements 17,965 — Furniture and fixtures 110,586 75,121 Total 330,407 287,203 Less: accumulated depreciation (186,512 ) (142,133) Fixed assets, net $ 143,895 $ 145,070

LOANS (Tables)

LOANS (Tables)	6 Months Ended
	Mar. 31, 2020
Accounting Policies [Abstract]
Long term loans ayable	Long-term loans payable consist of the following: March 31, 2020 September 30, 2019 Promissory notes $ 150,000 $ 150,000 Total $ 150,000 $ 150,000
Current loans payable	Current loans payable consist of the following: March 31, 2020 September 30, 2019 Promissory notes $ — $ 50,000 Insurance financing loans — 17,467 Current loans payable: — 67,467 Unamortized debt discount — — Total, net of unamortized discount $ — $ 67,467

CONVERTIBLE NOTES PAYABLE (Tabl

CONVERTIBLE NOTES PAYABLE (Tables)	6 Months Ended
	Mar. 31, 2020
Debt Disclosure [Abstract]
Short term convertible notes	Principal $ 1,250,000 Unamortized debt discount (427,502) Total, net of unamortized discount 822,498
Long term convertible notes	Principal $ 10,750,000 Unamortized debt discount (5,625,342) Total, net of unamortized discount $ 5,124,658

LEASES (Tables)

LEASES (Tables)	6 Months Ended
	Mar. 31, 2020
Debt Disclosure [Abstract]
Operating lease liabilities	Fiscal year ending September 30, 2020 $ 25,448 Fiscal year ending September 30, 2021 43,170 Total Lease Payments 68,618 Less: imputed interest (4,585) Total present value of lease liabilities $ 64,033

STOCK WARRANTS (Tables)

STOCK WARRANTS (Tables)	6 Months Ended
	Mar. 31, 2020
Accounting Policies [Abstract]
Schedule of Warrant Summary	Number of Warrant Shares Weighted Average Exercise Price Balance, September 30, 2019 1,314,063 $ 21.62 Warrants granted — $ — Warrants expired — — Warrants canceled — — Warrants exercised — — Balance, March 31, 2020 1,314,063 $ 21.62
Fair value assumptions	Fair value assumptions – Warrants: March 31, 2019 Risk free interest rate 2.46% -3.01% Expected term (years) 3-5 Expected volatility 265-268% Expected dividends 0%

STOCK OPTIONS (Tables)

STOCK OPTIONS (Tables)	6 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Other Liabilities Disclosure [Abstract]
Stock Options	Number of Option Shares Weighted Average Exercise Price Balance, September 30, 2019 81,254 $ 11.82 Options granted 233,233 $ 5.28 Options expired 25,000 8.00 Options cancelled — — Options exercised — — Balance, March 31, 2020 289,487 $ 6.88
Fair Value Assumptions	Fair value assumptions – Options: March 31, 2020 Risk free interest rate 0.85-1.73% Expected term (years) 3-5 Expected volatility 124%-209% Expected dividends 0%	Fair value assumptions – Options: March 31, 2019 Risk free interest rate 2.21-2.91% Expected term (years) 3 Expected volatility 256%-271% Expected dividends 0%

MAJOR CUSTOMER (Tables)

MAJOR CUSTOMER (Tables)	6 Months Ended
	Mar. 31, 2020
Notes to Financial Statements
Major Customers	March 31, 2020 March 31, 2019 Customer A 55.5 % 35.8% Customer B 24.4 % — Customer C — 44% Customer D — 14.2%
Major Suppliers	March 31, 2020 March 31, 2019 Vendor A 92.27 % 83.1%

ORGANIZATION AND LINE OF BUSI_2

ORGANIZATION AND LINE OF BUSINESS (Details Narrative)	6 Months Ended
	Mar. 31, 2020shares	Jan. 31, 2020USD ($)shares	Sep. 30, 2019shares	Jan. 22, 2019$ / sharesshares	Jul. 01, 2016USD ($)
Date of Incorporation	Oct. 15, 1987
Liabilities Assumed | $					$ 200,000
Common stock issued as consideration for acquisition	5,745,415	95,699	4,679,018	175,000
Reverse stock split ratio	0.1
Warrant One
Warrant issued as consideration for acquisition				50,000
Term of warrant				5 years
Warrant exercise price per share | $ / shares				$ 16
Warrant Two
Warrant issued as consideration for acquisition				50,000
Term of warrant				5 years
Warrant exercise price per share | $ / shares				$ 20
p2k
Common stock issued as consideration for acquisition		31,183
Aggregate purchase price | $		$ 1,688,935

SUMMARY OF SIGNIFICANT POLICI_3

SUMMARY OF SIGNIFICANT POLICIES - Fair Value of Financial Instruments (Details) - USD ($)	Mar. 31, 2020	Sep. 30, 2019
Derivative asset	$ 824,891
Investment in equity security	252,000
Investment debt security	456,744
Total financial instruments	1,533,635
Level 1
Derivative asset
Investment in equity security	252,000
Investment debt security
Total financial instruments	252,000
Level 2
Derivative asset
Investment in equity security
Investment debt security
Total financial instruments
Level 3
Derivative asset	824,891
Investment in equity security
Investment debt security	456,744
Total financial instruments	$ 1,281,635

SUMMARY OF SIGNIFICANT POLICI_4

SUMMARY OF SIGNIFICANT POLICIES - Fair Value of Drivative Asset (Details) - USD ($)	6 Months Ended
	Mar. 31, 2020	Sep. 30, 2019
Fair Value balance	$ 1,281,635
Fair value at issuance,net of premium	456,744
Gain on derivative asset	$ 824,891

SUMMARY OF SIGNIFICANT POLICI_5

SUMMARY OF SIGNIFICANT POLICIES (Details Narrative) - USD ($)	3 Months Ended				6 Months Ended
	Mar. 31, 2020	Dec. 31, 2019	Mar. 31, 2019	Dec. 31, 2018	Mar. 31, 2020	Mar. 31, 2019	Oct. 01, 2019	Sep. 30, 2019
Net loss	$ (5,815,098)	$ (1,916,254)	$ (7,764,540)	$ (2,283,551)	$ (7,731,352)	$ (10,048,091)
Woking Capital	3,713,881				3,713,881
Cash and no cash equivalents	4,506,510				4,506,510			$ 7,838,857
Revenues	3,658,283		$ 723,899		4,635,107	$ 986,806
Retention Receivables	158,300				158,300			159,989
Allowance for doubtful accounts. net of	373,285				373,285			254,570
Cash balance in excess of FDIC limits					4,256,510
Warranty costs and associated liabilities	0				0			0
Shares issuable upon excercise of outstanding options	9,603,552				9,603,552
Contract liablilities	590,241				590,241			499,401
Contract assets	611,000				611,000			360,000
Contract work in progress	4,282				4,282			$ 57,077
Long term convertible debt at fair value	$ 10,900,000				$ 10,900,000
Right of use asset							$ 85,280
Lease liability							$ 85,280

ACQUISITION OF P2K LABS, INC. -

ACQUISITION OF P2K LABS, INC. - Consideration (Details) - USD ($)	1 Months Ended
	Jan. 31, 2020	Mar. 31, 2020	Sep. 30, 2019	Jan. 22, 2019
Accounting Policies [Abstract]
Cash	$ 1,155,000
Common stock, shares issued	95,699	5,745,415	4,679,018	175,000
Common stock issued, value	$ 445,000	$ 5,745	$ 4,679
Common stock options, shares issued	26,950
Common stock options, value	$ 88,935

ACQUISITION OF P2K LABS, INC._2

ACQUISITION OF P2K LABS, INC. - Purchase Price Allocation (Details) - USD ($)	Mar. 31, 2020	Jan. 31, 2020	Sep. 30, 2019
Accounting Policies [Abstract]
Customer list	$ 6,767,024	$ 1,045,000	$ 5,722,024
Design and other assets		123,000
Goodwill	$ 5,562,246	642,388	$ 4,919,858
Other assets and liabilities assumed, net		$ (121,453)

ACQUISITION OF P2K LABS, INC._3

ACQUISITION OF P2K LABS, INC. - Pro Forma Information (Details) - USD ($)	3 Months Ended				6 Months Ended
	Mar. 31, 2020	Dec. 31, 2019	Mar. 31, 2019	Dec. 31, 2018	Mar. 31, 2020	Mar. 31, 2019
Net sales	$ 3,658,283		$ 723,899		$ 4,635,107	$ 986,806
Net loss	$ (5,815,098)	$ (1,916,254)	$ (7,764,540)	$ (2,283,551)	$ (7,731,352)	$ (10,048,091)
Loss per common share - basic and diluted	$ (1.13)		$ (1.88)		$ (1.56)	$ (2.59)
Weighted average common shares outstanding - basic and diluted	5,135,802		4,121,963		4,957,491	3,884,818
p2k
Net sales	$ 3,716,725		$ 924,906		$ 5,006,806	$ 1,409,906
Net loss	$ (5,970,217)		$ (7,770,325)		$ (7,851,673)	$ (10,044,709)
Loss per common share - basic and diluted	$ (1.15)		$ (1.84)		$ (1.56)	$ (2.52)
Weighted average common shares outstanding - basic and diluted	5,188,384		4,217,662		5,031,749	3,980,517

ACQUISITION OF P2K LABS, INC._4

ACQUISITION OF P2K LABS, INC. (Details Narrative) - USD ($)	1 Months Ended
	Jan. 31, 2020	Mar. 31, 2020	Sep. 30, 2019	Jan. 22, 2019
Cash paid for acquisition	$ 1,155,000
Common stock, shares issued	95,699	5,745,415	4,679,018	175,000
Common stock issued, value	$ 445,000	$ 5,745	$ 4,679
Common stock options, shares issued	26,950
Common stock options, value	$ 88,935
p2k
Aggregate purchase price	1,688,935
Cash paid for acquisition	$ 1,039,500
Common stock, shares issued	31,183
Common stock issued, value	$ 145,000
Common stock options, shares issued	26,950
Common stock options, value	$ 88,935
Lock up provisions	Seller may sell an amount of Shares equal to ten percent (10%) of the daily dollar trading volume of the Company’s common stock on its principal market for the prior 30 days
Third Party
Cash paid for acquisition	$ 115,500
Common stock, shares issued	64,516
Common stock, value per share	$ 4.65
Lock up provisions	The Holdback Shares will also be subject to the Leak-Out Terms once they are released from escrow 12 months from closing.

INVESTMENTS IN INTERNATIONAL _3

INVESTMENTS IN INTERNATIONAL LAND ALLIANCE - (Details) - International Land Alliance SPA	6 Months Ended
	Mar. 31, 2020
Risk free interest rate	1.58%
Expected term (months)	7 months
Expected volatility	190.00%
Expected dividends	0.00%

INVESTMENTS IN INTERNATIONAL _4

INVESTMENTS IN INTERNATIONAL LAND ALLIANCE (Details Narrative) - USD ($)	Nov. 06, 2019	Mar. 31, 2020	Jan. 31, 2020	Sep. 30, 2019
Common stock issued, value		$ 5,745	$ 445,000	$ 4,679
International Land Alliance SPA
Series B preferred stock purchased, shares	1,000
Series B preferred stock purchased, price	$ 500,000
Rate of accruals per annum	12.00%
Description of conversion terms	The Series B Preferred Stock will accrue cumulative in kind accruals at a rate of 12% per annum and shall increase by 10% per annum upon the occurrence of any trigger event. ILAL may redeem by paying in cash within 9 months from the issuance date. The Preferred Stock becomes convertible into common stock after 9 months or when certain triggering events occur. In the event of a conversion of any shares of the Preferred Stock, the number of conversion shares is equal to the face value of the Preferred Stock divided by the applicable Conversion Price (defined at 65% of the 5 lowest individual daily volume weighted average prices of the Common Stock from issuance to conversion less $0.05 per share, but no less than the Floor Price ($0.01). While the Preferred Stock is outstanding if triggering events occur, the Conversion Pate may be decreased by 10% and the accrual rate increased by 10% for each triggering event.
Common stock issued as commitment	350,000
Common stock issued, value		$ 252,000
Common stock, value per share		$ .72

CAPITALIZED SOFTWARE (Details)

CAPITALIZED SOFTWARE (Details) - USD ($)	Mar. 31, 2020	Sep. 30, 2019
Fair Value Disclosures [Abstract]
mVSO software	$ 437,136	$ 352,211
mPulse software	741,846	741,846
Capitalized software	1,178,982	1,094,057
Accumulated Amortization	(118,565)	(38,860)
Capitalized Software, net	$ 1,060,417	$ 1,055,197

CAPITALIZED SOFTWARE (Details N

CAPITALIZED SOFTWARE (Details Narrative) - USD ($)	6 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Cost of revenues and product development expense	$ 79,705	$ 689,741

INTANGIBLE ASSETS - Schedule o

INTANGIBLE ASSETS - Schedule of Intangible Assets (Details) - USD ($)	Mar. 31, 2020	Jan. 31, 2020	Sep. 30, 2019
Goodwill and Intangible Assets Disclosure [Abstract]
Patents	$ 74,112		$ 74,112
Websites	8,115		16,482
Customer list and non-compete agreement	6,767,024	$ 1,045,000	5,722,024
Design assets	123,000
Trademarks	5,928		5,928
Engineering trade secrets	4,370,269		4,370,269
Intangible assets	11,348,448		10,188,815
Less: accumulated depreciation	(4,019,659)		(2,758,082)
Intangible Assets, Net	$ 7,328,789		$ 7,430,082

INTANGIBLE ASSETS (Details Narr

INTANGIBLE ASSETS (Details Narrative) - USD ($)	6 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Accounting Policies [Abstract]
Amortization Expense	$ 1,269,293	$ 635,955

FIXED ASSETS - Schedule of Prop

FIXED ASSETS - Schedule of Property Pant and Equipment (Details) - USD ($)	Mar. 31, 2020	Sep. 30, 2019
Property, Plant and Equipment [Abstract]
Machinery and equipment	$ 201,856	$ 212,082
Leashold improvements	17,965
Furniture and fixtures	110,586	75,121
Total	330,407	287,203
Less: accumulated depreciation	186,512	142,133
Fixed assets, net	$ 143,895	$ 145,070

FIXED ASSETS (Details Narrative

FIXED ASSETS (Details Narrative) - USD ($)	6 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Accounting Policies [Abstract]
Depreciation Expense	$ 32,071	$ 21,164

LOANS - Long Term (Details)

LOANS - Long Term (Details) - USD ($)	Mar. 31, 2020	Sep. 30, 2019
Debt Disclosure [Abstract]
Promissory Notes	$ 150,000	$ 150,000
Total	$ 150,000	$ 150,000

LOANS - Current (Details)

LOANS - Current (Details) - USD ($)	Mar. 31, 2020	Sep. 30, 2019
Debt Disclosure [Abstract]
Prommisory Notes		$ 50,000
Insurance financing loans		17,467
Current loans payable		67,467
Unamortized Debt Discount
Total Net Of Unamortized Discount		$ 67,467

LOANS (Details Narrative)

LOANS (Details Narrative) - USD ($)	Jan. 13, 2020	Feb. 11, 2019	Dec. 05, 2017	Nov. 11, 2017	Sep. 05, 2017	Aug. 26, 2019	Mar. 31, 2020	Mar. 31, 2019	Mar. 31, 2020	Mar. 31, 2019	Sep. 30, 2019
Accrued Interest										$ 4,725,000
Interest Expense							$ 1,891,283	$ 5,183,657	3,451,598	5,701,074
Loans Payable 1
Promissory note, interest rate					9.00%
Proceeds from promissory note					$ 150,000
Maturity Date					Sep. 5, 2021
Term of repayment					24 months
Accrued Interest					$ 0
Shares used to secure note					15,000
Interest Expense					$ 3,402				6,767	6,729
Shares held as collateral returned to treasury					10,000
Loans Payable 1
Promissory note, face value					$ 150,000
Owed in principal							$ 150,000		150,000
Loans Payabe 2
Promissory note, face value				$ 100,000
Loans Payable 2
Promissory note, interest rate				10.00%
Proceeds from promissory note				$ 100,000
Term of repayment				24 months
Shares used to secure note				10,000
Interest Expense									0	4,985
Shares held as collateral returned to treasury						10,000
Loans Payable 3
Promissory note, interest rate			9.00%
Proceeds from promissory note			$ 50,000
Maturity Date			Dec. 31, 2018
Term of repayment			24 months
Shares used to secure note			500
Interest Expense									$ 802	$ 2,247
Shares held as collateral returned to treasury	5,000
Loans Payable 3
Promissory note, face value			$ 50,000
Installment Loan
Promissory note, interest rate		5.60%
Promissory note, face value		$ 78,603
Proceeds from promissory note		$ 78,603
Term of repayment		10 months
Owed in principal											$ 17,467

CONVERTIBLE NOTES PAYABLE - Lon

CONVERTIBLE NOTES PAYABLE - Long Term Convertible Note Payable (Details) - USD ($)	6 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Principal of long term convertible notes		$ 555,000
Convertible Debenture[Member]
Principal of long term convertible notes	1,250,000
Unamortized debt discount	427,502
Total, net of unamortized discount	822,498
Convertible Debenture Two[Member]
Principal of long term convertible notes	10,750,000
Unamortized debt discount	5,625,342
Total, net of unamortized discount	$ 5,124,658

CONVERTIBLE NOTES PAYABLE - (De

CONVERTIBLE NOTES PAYABLE - (Details Narrative) - USD ($)

May 08, 2020

May 07, 2020

May 06, 2020

May 05, 2020

Mar. 13, 2020

Mar. 05, 2020

Mar. 04, 2020

Mar. 02, 2020

Feb. 10, 2020

Dec. 05, 2019

Jul. 09, 2019

Mar. 06, 2019

Jan. 07, 2019

Mar. 20, 2020

Feb. 21, 2020

Oct. 17, 2019

Sep. 16, 2019

Aug. 23, 2019

Jul. 19, 2019

Jul. 16, 2019

Apr. 17, 2019

Dec. 31, 2018

Mar. 31, 2020

Jan. 31, 2020

Sep. 30, 2019

Mar. 31, 2019

Jan. 22, 2019

Common stock, shares issued

5,745,415

95,699

4,679,018

175,000

Series B preferred shares issued

1,750,000

1,000,000

$75.00 Per Share

Warrant exercise price per share

$ 75

Warrant shares issued

33,333

SPA 1

Aggregate Face Value

$ 5,250,000

Maturity period

2 years

Note Terms

The note is secured by all assets of the Company. The Debenture has a maturity date of two years from the issuance date and the Company has agreed to pay compounded interest on the unpaid principal balance of the Debenture at the rate equal 7.5% per annum. Interest is payable on the date the applicable principal is converted or on maturity. The interest must be paid in cash and, in certain circumstances, may be paid in shares of common stock.

Interest Rate

7.50%

Common stock, shares issued

10,000

Debt discount

$ 4,995,000

Due diligence fees paid

5,000

Tendered to company

$ 5,000,000

Conversion terms

The Investor may convert the Debenture into shares of the Company’s common stock at a conversion price equal to 95% of the mathematical average of the 5 lowest individual daily volume weighted average prices of the common stock, less $0.50 per share, during the period beginning on the issuance date and ending on the maturity date subject to certain floor price restrictions. In the event certain equity conditions exist, the Company may require that the Investor convert the Debenture. In no event shall the Debenture be allowed to affect a conversion if such conversion, along with all other shares of Company common stock beneficially owned by the Investor and its affiliates would exceed 4.99% of the outstanding shares of the common stock of the Company. While the note is outstanding if Triggering Events occur the conversion rate may be decreased by 10% and the interest rate increased by 10% for each Triggering Event.

Percent adjustment to conversion and interest rate upon default

$ 0.10

Debt discount charged as financing expense

$ 355,972

SPA 1 | Conversion 1

Principal converted

$ 2,500,000

Interest converted

$ 875,000

Common stock issued in conversion

178,473

Effective conversion price per share

$ 18.90

SPA 1 | Conversion 2

Principal converted

$ 1,000,000

Interest converted

$ 375,000

Common stock issued in conversion

71,389

Effective conversion price per share

$ 18.90

SPA 1 | Issuance 1

Common stock issued in conversion

45,614

Effective conversion price per share

$ 15.06

SPA 1 | Issuance 2

Common stock issued in conversion

18,246

Effective conversion price per share

$ 15.06

SPA 1 | Conversion 3

Principal converted

$ 500,000

Interest converted

$ 175,000

Common stock issued in conversion

45,109

Effective conversion price per share

$ 15

SPA 1 | Conversion 4

Principal converted

$ 750,000

Interest converted

$ 112,500

Common stock issued in conversion

575,000

SPA 1 | Conversion 5

Principal converted

$ 600,000

Interest converted

$ 90,000

Common stock issued in conversion

460,000

SPA 1 | Conversion 6

Principal converted

$ 595,000

Interest converted

$ 87,250

Common stock issued in conversion

456,167

SPA 1 | Conversion 7

Principal converted

$ 350,000

Interest converted

$ 52,500

Common stock issued in conversion

268,333

SPA 1 | Issuance 3

Common stock issued in conversion

43,721

Effective conversion price per share

$ 7.60

SPA 1 | Issuance 4

Common stock issued in conversion

61,500

Effective conversion price per share

$ 7.30

SPA 1 | Issuance 5

Common stock issued in conversion

90,000

Effective conversion price per share

$ 3.74

SPA 1 | Issuance 6

Common stock issued in conversion

97,100

Effective conversion price per share

$ 3.15

SPA 1 | Issuance 7

Common stock issued in conversion

100,000

Effective conversion price per share

$ 3.15

SPA 1 | Issuance 8

Common stock issued in conversion

108,770

Effective conversion price per share

$ 2.69

SPA 1 | Issuance 9

Common stock issued in conversion

167,100

Effective conversion price per share

$ 1.87

SPA 1 | Issuance 10

Common stock issued in conversion

54,835

Effective conversion price per share

$ 1.83

SPA 1 | Issuance 11

Common stock issued in conversion

116,000

Effective conversion price per share

$ 1.50

SPA 1 | Issuance 12

Common stock issued in conversion

163,800

Effective conversion price per share

$ 1.50

SPA 1 | $20.00 Per Share

Warrant exercise price per share

$ 20

Warrant shares issued

125,000

SPA 1 | $25.00 Per Share

Warrant exercise price per share

$ 25

Warrant shares issued

100,000

SPA 1 | $50.00 Per Share

Warrant exercise price per share

$ 50

Warrant shares issued

50,000

SPA 2

Aggregate Face Value

$ 10,750,000

Aggregate purchase price

$ 20,000,000

Maturity period

2 years

Interest Rate

7.50%

Common stock, shares issued

125,000

Common stock, shares issued, cash only basis

230,000

Tendered to company

$ 10,000,000

Conversion terms

The Investor may convert the Debenture into shares of the Company’s common stock at a conversion price equal to 90% of the mathematical average of the 5 lowest individual daily volume weighted average prices of the common stock, less $0.75 per share, during the period beginning on the issuance date and ending on the maturity date subject to certain floor price restrictions. In the event certain equity conditions exist, the Company may require that the Investor convert the Debenture. In no event shall the Debenture be allowed to effect a conversion if such conversion, along with all other shares of Company common stock beneficially owned by the Investor and its affiliates would exceed 4.99% of the outstanding shares of the common stock of the Company. While the note is outstanding if Triggering Events occur the conversion rate may be decreased by 10% and the interest rate increased by 10% for each Triggering Event.

Percent adjustment to conversion and interest rate upon default

$ 0.10

Debt discount charged as financing expense

$ 2,694,863

Series B preferred shares issued

215

Series B preferred shares issued, original issue discount

$ 0.075

Default Trigger Original

Conversion terms

While the note is outstanding if Triggering Events occur the conversion rate may be decreased by 10% and the interest rate increased by 10% for each Triggering Event.

Closing price of common stock default trigger

500.00%

Default Trigger Amended

Closing price of common stock default trigger

175.00%

LEASES (Details)

LEASES (Details) - USD ($)	12 Months Ended
	Sep. 30, 2019	Sep. 30, 2021	Sep. 30, 2020	Mar. 31, 2020	Oct. 01, 2019
Debt Disclosure [Abstract]
Lease liabilities		$ 43,170	$ 25,448	$ 64,033	$ 85,280
Total Lease Payments	$ 68,618
Less: imputed interest	(4,585)
Total present value of lease liabilities	$ 74,789

LEASES (Details Narrative)

LEASES (Details Narrative) - USD ($)	6 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Sep. 30, 2021	Sep. 30, 2020	Oct. 01, 2019	Sep. 30, 2019
Operating lease costs	$ 48,459	$ 38,523
Day one recognition of right of use asset and liability	85,280
Operating lease right of use	63,554				$ 85,280
Operating lease liability	$ 64,033		$ 43,170	$ 25,448	$ 85,280
Weighted average discount rate					10.00%
Weighted average lease term	10 months 24 days
Lease Term Minimum
Lease terms	1 year
Lease Term Maximum
Lease terms	2 years

RELATED PARTY TRANSACTIONS (Det

RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)	Mar. 12, 2019	Sep. 28, 2018	Mar. 31, 2020	Mar. 31, 2019	Jan. 01, 2019
Consulting Agmt ZRB Holdings, Inc.
Officer wages				$ 190,140
Blue Chip Accounting, LLC
Payments for accounting, tax, and admininstrative services			$ 55,199
Payments for rent			5,575
Consulting Agmt Zero Positive
Officer wages	$ 90,000		$ 125,154	85,209
Warrant shares issued		90,000
Warrants issued, exercise price		$ 8
Warrants issued, value		$ 2,607,096
Term of Warrant		10 years
Risk free interest rate		3.05%
Dividend Yield		0.00%
Volatility Rate		191.00%
Warrants vested		30,000	54,286
Warrants issued, vesting description		The warrants vest as follows: 30,000 vested immediately, the balance vest evenly on the last day of each month over forty-two months beginning August 31, 2018
Interest Expense			$ 248,295	248,295
Consulting Agmt Schultz
Officer wages			0	48,000
Director compensation			126,000
Investor Relations and Consulting Services
Payments for consulting services			49,500
Payment for reimbursement			176,000
McNeill
Director compensation			15,000	15,000
Non Executive Board Members
Board member annual wage					$ 2,500
Beynon
Director compensation			15,000	0
Dr. Wood
Director compensation			$ 15,000	$ 0

STOCKHOLDERS' EQUITY (Details N

STOCKHOLDERS' EQUITY (Details Narrative)	Feb. 10, 2020shares	Jan. 13, 2020shares	Dec. 11, 2019	Oct. 04, 2019USD ($)$ / sharesshares	Mar. 06, 2019USD ($)$ / sharesshares	Jan. 08, 2019shares	Jan. 07, 2019USD ($)$ / sharesshares	Sep. 11, 2018USD ($)	Mar. 26, 2019$ / sharesshares	Feb. 26, 2019shares	Dec. 31, 2018USD ($)shares	Dec. 21, 2018shares	Oct. 02, 2018USD ($)$ / sharesshares	Mar. 31, 2020USD ($)$ / sharesshares	Dec. 31, 2019USD ($)	Mar. 31, 2019USD ($)	Dec. 31, 2018USD ($)	Mar. 31, 2020USD ($)$ / sharesshares	Mar. 31, 2019USD ($)shares	Jan. 31, 2020USD ($)shares	Sep. 30, 2019USD ($)$ / sharesshares	Aug. 09, 2019shares	Aug. 08, 2019shares	Feb. 01, 2019$ / shares	Jan. 22, 2019shares
Common stock authorized														20,000,000				20,000,000			100,000,000	200,000,000	100,000,000
Common stock, par value | $ / shares														$ 0.001				$ 0.001			$ 0.001
Common stock, shares issued														5,745,415				5,745,415		95,699	4,679,018				175,000
Common stock issued, Value | $														$ 5,745				$ 5,745		$ 445,000	$ 4,679
Stock issued for services				750,000
Stock issued, fair value per share | $ / shares				$ 0.02
Director fees | $				$ 15,000
Preferred stock authorized														10,000,000				10,000,000			10,000,000
Preferred stock, par value | $ / shares														$ 0.001				$ 0.001			$ 0.001
Preferred Stock, shares issued and outstanding														1,750,000				1,750,000			1,000,000
Payments received for stock issuance | $																			$ 361,800
Shares issued for direct investment, value | $																	$ 361,800	$ 361,800
Reverse stock split ratio																		0.1
Convertible Debt Agreement [Member]
Common stock issued during period																		997,605
Independent Consultant [Member]
Stock issued for services																		2,000
Fourteen Investors [Member]
Common stock, par value | $ / shares													$ 0.001
Common stock issued during period																			45,225
Common stock issued for direct investment																			45,225
Payments received for stock issuance | $																			$ 361,800
Regal Consulting LLC [Member]
Common stock issued during period																			18,000
Commitment fees | $								$ 3,000
Stock Compensation | $								$ 531,600
Consultant [Member]
Date of Issuance																			Oct. 15, 2018
Commitment fees | $																			$ 3,000
Stock Compensation | $																			$ 68,819
Warrants [Member]
Common stock, par value | $ / shares													$ 0.001
Warrant exercised to purchase shares													300
Warrant, exercise price | $ / shares													$ 3.63
Warrant value to company | $													$ 1,088
SPA 1
Date of Issuance																		Dec. 31, 2018
Common stock issued during period																		10,000
Promissory Note [Member]
Date of Issuance											Dec. 31, 2018
Common stock issued during period											2,500
Common stock issued for direct investment											2,500
Shares issued for direct investment, value | $											$ 51,225
Loss on settlement of debt | $											26,225
Payment for debt settlement | $											$ 25,000
Returnable Shares [Member]
Shares returned to treasury												13,750
Note Payoff [Member]
Shares returned to treasury		5,000
Note Payoff 2 [Member]
Shares returned to treasury						13,750
Contract Cancellation [Member]
Shares returned to treasury	25,000
Cashless Exercise [Member]
Common stock issued during period							144,417
Warrant exercised to purchase shares							150,000
Warrant, exercise price | $ / shares							$ 0.83
Investor Conversion 1 [Member]
Principal converted | $							$ 2,500,000
Interest converted | $							$ 875,000
Common stock issued in conversion							178,472
Conversion price per share | $ / shares							$ 18.90
Merger Agreement [Member]
Common stock, shares issued																									175,000
Cashless Exercise 2 [Member]
Common stock issued during period										24,628
Warrant exercised to purchase shares										25,000
Warrant, exercise price | $ / shares																								$ .83
Investor Conversion 2 [Member]
Principal converted | $					$ 1,000,000
Interest converted | $					$ 350,000
Common stock issued in conversion					71,389
Conversion price per share | $ / shares					$ 18.90
Cashless Exercise 3 [Member]
Common stock issued during period									48,857
Warrant exercised to purchase shares									50,000
Warrant, exercise price | $ / shares									$ 0.83
Reverse Split
Common stock authorized																						20,000,000
Common stock issued during period																		793
Reverse stock split ratio			0.1
Reverse stock split			On December 10, 2019, the Financial Industry Regulatory Authority (“FINRA”) approved the Company’s 1:10 reverse stock split of the Company’s common stock. The reverse stock split took effect on December 11, 2019. Unless otherwise noted, impacted amounts and share information in the consolidated financial statements and notes thereto as of and for the periods ended December 31, 2019 and September 30, 2019, have been adjusted for the stock split as if such stock split occurred on the first day of the first period presented.
p2k
Common stock issued during period																		95,699

STOCKHOLDERS' EQUITY - Amendmen

STOCKHOLDERS' EQUITY - Amendment to Articles of Incorporation (Details Narrative) - $ / shares	6 Months Ended
	Mar. 31, 2020	Oct. 04, 2019	Oct. 03, 2019	Sep. 30, 2019	Aug. 09, 2019	Aug. 08, 2019
Common Stock authorized	20,000,000			100,000,000	200,000,000	100,000,000
Preferred stock designated, series A	10,000,000			10,000,000
Preferred stock, par value	$ 0.001			$ 0.001
Reverse Split
Common Stock authorized					20,000,000
Seires A Preferred
Preferred stock designated, series A		2,000,000	1,000,000
Preferred stock, par value		$ 0.001	$ 0.001
Preferred stock rights	Under the Certificate of Designation, holders of Series A Preferred Stock will be entitled to quarterly dividends on 2% of our earnings before interest, taxes and amortization. The dividends are payable in cash or common stock. The holders will also have a liquidation preference on the state value of $0.02 per share plus any accumulated but unpaid dividends. The holders are further entitled to have us redeem their Series A Preferred Stock for three shares of common stock in the event of a change of control and they are entitled to vote together with the holders of our common stock on all matters submitted to shareholders at a rate of forty-five (45) votes for each share held.
Preferred stock, dividend rate	2.00%
Preferred stock, liquidation preference		$ 0.02
Preffered stock, common shares issued upon conversion		3

STOCKHOLDERS' EQUITY - Certific

STOCKHOLDERS' EQUITY - Certificate of Preferred Stock Designation (Details Narrative) - USD ($)	1 Months Ended
	Apr. 16, 2019	Mar. 31, 2020	Sep. 30, 2019
Preferred stock authorized		10,000,000	10,000,000
Series B preferred stock, par value per share		$ 0.001	$ 0.001
Series B preferred stock issued and outstanding		1,750,000	1,000,000
Series B Preferred
Preferred stock authorized	100,000
Series B preferred stock, par value per share	$ 0.001
Series B preferred stock issued and outstanding	0
Cumulative accrual rate	7.50%
Liquidation payout	$ 5,000
Early redemption percent of face value option	145.00%
Max percent holders may own of series B preferred	4.99%
Maturity term from issuance	2 years
Terms of Conversion	In the event of a conversion of any shares of Series B Preferred Stock, the Company will (a) satisfy the payment of the Conversion Premium, which is defined as the Face Value of the shares converted multiplied by the product of 7.5% and the number of whole years between issuance and maturity, and (b) issue to the holder of the shares of Series B Preferred Stock a number of conversion shares equal to the Face Value divided by the applicable Conversion Price (defined as 90% of the of the 5 lowest individual daily volume weighted average prices of the Common Stock from issuance to conversion less $0.75 per share, but no less than the Floor Price ($3.50) with respect to the number of shares converted; While the note is outstanding if Triggering Events occur the conversion rate may be decreased by 10% and the interest rate increased by 10% for each Triggering Event. In the event of certain defaults, conversion price may not be subject to a floor.

STOCK WARRANTS - Schedule of Wa

STOCK WARRANTS - Schedule of Warrant Summary (Details) - $ / shares	6 Months Ended
	Mar. 31, 2020	Sep. 30, 2019
Accounting Policies [Abstract]
Beginning Balance, number of shares	1,314,063
Warrants Granted and Assumed, number of shares
Warrants Granted and Assumed, weighted average exercise price
Warrants exercised, number of shares
Warrants expired, number of shares
Warrants expired, weighted average exercise price
Warrants cancelled, number of shares
Warrants cancelled, weighted average exercise price
Ending Balance, number of shares	1,314,063
Ending Balance, weighted average exercise price	$ 21.62	$ 21.62

STOCK WARRANTS (Details Narrati

STOCK WARRANTS (Details Narrative) - USD ($)	Jan. 07, 2019	Oct. 15, 2018	Mar. 26, 2019	Feb. 26, 2019	Jan. 22, 2019	Dec. 31, 2018	Aug. 28, 2018	Mar. 31, 2020	Mar. 31, 2019	Feb. 01, 2019
Stock based compensation								$ 91,045	$ 1,283,782
Warrants weighted average remaining term								2 years 4 months 24 days
Warrants Exercisable								1,282,636
Warrants requiring cash investment								$ 996,198
Warrants containing cashless provisions								317,865
Unvested Warrants outstanding								31,429
Intrinsic Value of outstanding warrants								$ 88,500
Weighted Average remaining term of warrants								2 years
Consultant
Warrant price per share		$ 25
Common stock issued		3,000
Warants issued, exercise price		$ 25
Common stock issued during period		3,000
Consultant [Member]
Stock based compensation								$ 0	68,643
Term of Warrant								5 years
SPA [Member]
Date of Agreement						Dec. 31, 2018
Warrant issued, shares						308,333
Term of Warrant						3 years
Zero Positive LLC
Warrant price per share							$ 8
Zero Positive [Member]
Warrant issued, shares							90,000
Warrants issued, value							$ 2,607,096
Warrants vested description							30,000 warrants vested immediately, the balance vest evenly on the last day of each month over the forty-two months beginning August 31, 2018
Warrants vested							30,000	54,286
Warrant expense								$ 124,147	124,147
SPA 2
Term of Warrant								3 years
Merger Agreement [Member]
Warrant issued, shares					50,000
Warrants issued, value					$ 1,102,417
Warants issued, exercise price					$ 16
Term of Warrant					5 years
Merger Agreement 2[Member]
Warrant issued, shares					50,000
Warrants issued, value					$ 1,102,107
Warants issued, exercise price					$ 20
Term of Warrant					5 years
Cashless Exercise [Member]
Common stock issued	144,417
Common stock issued during period	144,417
Warrant exercised to purchase shares	150,000
Warrant, exercise price	$ 0.83
Cashless Exercise 2 [Member]
Common stock issued				24,628
Common stock issued during period				24,628
Warrant exercised to purchase shares				25,000
Warrant, exercise price										$ .83
Cashless Exercise 3 [Member]
Common stock issued			48,857
Common stock issued during period			48,857
Warrant exercised to purchase shares			50,000
Warrant, exercise price			$ 0.83
$20.00 Per Share
Warrants requiring cash investment									125,000
$20.00 Per Share | SPA [Member]
Warrants requiring cash investment						$ 125,000
$25.00 Per Share
Warrants requiring cash investment									103,000
$25.00 Per Share | SPA [Member]
Warrants requiring cash investment						100,000
$50.00 Per Share
Warrants requiring cash investment									60,000
$50.00 Per Share | SPA [Member]
Warrants requiring cash investment						50,000
$75.00 Per Share
Warrants requiring cash investment									$ 38,333
Warrant, exercise price									$ 75
$75.00 Per Share | SPA [Member]
Warrants requiring cash investment						$ 33,333
$8.00 Per Share
Warrants requiring cash investment									$ 5,000
$15.00 Per Share
Warrants requiring cash investment									449,865
$35.00 Per Share
Warrants requiring cash investment									200,000
$40.00 Per Share
Warrants requiring cash investment									10,000
$100.00 Per Share
Warrants requiring cash investment									$ 5,000

STOCK OPTIONS - Schedule of Opt

STOCK OPTIONS - Schedule of Option Summary (Details) - $ / shares	6 Months Ended
	Mar. 31, 2020	Sep. 30, 2019
Beginning Balance, number of shares	1,314,063
Options Granted and Assumed, number of shares
Options Granted and Assumed, weighted average exercise price
Options expired, number of shares
Ending Balance, number of shares	1,314,063
Options
Beginning Balance, number of shares	81,254
Options Granted and Assumed, number of shares	233,233
Options Granted and Assumed, weighted average exercise price	$ 5.28
Options expired, number of shares	25,000
Options expired, weighted average exercise price	$ 8
Ending Balance, number of shares	289,487
Ending Balance, weighted average exercise price		$ 11.82

STOCK OPTIONS - Fair Value Ass

STOCK OPTIONS - Fair Value Assumptions (Details)	6 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Risk Free Interest Rate Min	85.00%	221.00%
Risk Free Interest Rate Max	173.00%	291.00%
Expected Dividends	0.00%	0.00%
Expected Term Minimum
Exptected Term in years Min	3 years	3 years
Expected Term Maximum
Exptected Term in years Min	5 years	3 years
Expected Volatility Minimum
Expected Volatility Min	12400.00%	25600.00%
Expected Volatility Maximum
Expected Volatility Min	20900.00%	27100.00%

STOCK OPTIONS (Details Narrativ

STOCK OPTIONS (Details Narrative) - USD ($)	Mar. 10, 2018	Mar. 31, 2020	Mar. 31, 2019	Jun. 19, 2017
Shares reserved for issuance				300,000
Shares available for issuance		10,513
Options exercisable to purchase		261,577
Unvested options outstanding		291,084
Stock based compensation		$ 91,045	$ 1,283,782
Weighted Average remaining term options		2 years 5 months 25 days
Weighted average period for non vested options		2 years 6 months 4 days
MinimumMarketPrice
Market Price		$ 4.50	$ 15.10
MaximumMarketPrice
Market Price		$ 8.50	$ 59
Employees
Compensation expense		$ 716,740
Options issued		233,233	11,737
Four Consultants
Options issued	25,000
Vesting Period	12 months
Expiration of Options Period	24 months
Stock based compensation			$ 191,425

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)	May 15, 2018	Mar. 31, 2020	Sep. 30, 2021	Sep. 30, 2020
Utah Corporate Ofice
Monthly Rent Expense		$ 2,300
San Diego Office
Monthly Rent Expense	$ 4,057
Term of Agreement	37 months
Term of Agreement After Year One	1 month
Future minimum lease payments			$ 43,170	$ 25,448
Annual Rent Excalation	3.00%
Las Vegas Office
Monthly Rent Expense		1,575
p2k Labs Lease
Monthly Rent Expense		$ 1,801

MAJOR CUSTOMERS AND VENDORS - C

MAJOR CUSTOMERS AND VENDORS - Customers (Details)	6 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Percent of sales	10.00%	10.00%
Customer A
Percent of sales	55.50%	35.80%
Customer B
Percent of sales	24.40%
Customer C
Percent of sales		44.00%
Customer D
Percent of sales		14.20%

MAJOR CUSTOMERS AND VENDORS - S

MAJOR CUSTOMERS AND VENDORS - Suppliers (Details)	6 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Percent supplies provided	10.00%	10.00%
Vendor A
Percent supplies provided	92.27%	83.10%

MAJOR CUSTOMER (Details Narrati

MAJOR CUSTOMER (Details Narrative)	6 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Notes to Financial Statements
Customer Representation Percentage	10.00%	10.00%
Supplier Representaion Percentage	10.00%	10.00%

SUBSEQUENT EVENTS (Details Narr

SUBSEQUENT EVENTS (Details Narrative) - USD ($)	May 11, 2020	May 08, 2020	May 07, 2020	May 06, 2020	May 05, 2020	Apr. 09, 2020	Apr. 08, 2020	Apr. 06, 2020	Apr. 15, 2020
Capital contribution								$ 660,000
Investor 1
Common stock issued							172,400
Effective conversion price per share							$ 1.50
Investor 2
Common stock issued						794,308
Effective conversion price per share						$ 1.50
Investor 3
Common stock issued									1,125,000
Effective conversion price per share									$ 1.50
Principal converted									$ 1,250,000
Interest converted									$ 437,500
Investor 4
Common stock issued					575,000
Effective conversion price per share					$ 1.50
Principal converted					$ 750,000
Interest converted					$ 112,500
Investor 5
Common stock issued				460,000
Effective conversion price per share				$ 1.50
Principal converted				$ 600,000
Interest converted				$ 90,000
Investor 6
Common stock issued			456,167
Effective conversion price per share			$ 1.50
Principal converted			$ 595,000
Interest converted			$ 87,250
Investor 7
Common stock issued		268,333
Effective conversion price per share		$ 1.5
Principal converted		$ 350,000
Interest converted		$ 52,500
Investor 8
Common stock issued	268,333
Effective conversion price per share	$ 1.50
Principal converted	$ 350,000
Interest converted	$ 52,500